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Background
Despite all measures put in place in the controlling of childhood overweight, its 
prevalence, severity, and societal burden have increased over the past decades.1-3 In general, 
overweight is the result of an imbalance in energy intake and energy expenditure, over 
a long period.4,5 In 2009, 12.8% of Dutch boys and 14.8% of Dutch girls aged 2-21 
years were overweight, while 1.8% of the boys and 2.2% of the girls were classified as 
obese. This resulted in a two to three-fold increase in the prevalence of overweight and 
four to six-fold increase in obesity since 1980.6 Moreover, it has been predicted that 8% 
of men and 9% of women will suffer from obesity by 2030.7 Childhood overweight is a 
major health concern because of its dramatic increasing prevalence, its persistency into 
adulthood, association with relative number of detrimental health outcomes such as type 
2 diabetes,8 and burden on the healthcare systems. It is proposed that the prevention and 
management of this pandemic should begin in childhood9 as treatment has been shown 
to be difficult for children already suffering from obesity10. Numerous factors that are 
subjected to genetic, environmental and behavioural influences (e.g., dietary intake or 
food habits, physical activity or sedentary lifestyles, and sleep duration)11-16 have been 
suggested to be associated with obesity. Even though some of these factors have been 
established as causal factors, the etiology of overweight and obesity remains complex 
and this makes it challenging to develop effective preventive programs and strategies.17 
Moreover, there is growing evidence that the increasing prevalence of obesity might not 
only be explained by these factors. Recent studies (reviewed in18) have proposed that the 
composition of the gut microbiota (the community of microorganisms that live in the 
intestinal tract) may be a potential factor associated with obesity. 
The human gut microbiota 
The gastrointestinal (GI) tract is inhibited by almost 1000 microbial species (including 
bacteria, archaea and eukaryotic microorganisms), which collectively contain 3.3 million 
unique genes19 and are referred to as the GI microbiome. The density of microbial cells 
increases along the length of the intestine to almost 1011 – 1012 per gram of luminal 
content in the distal colon (Figure 1).20 Additionally, the diversity of microorganisms 
in the colon exceeds the diversity in other parts of the intestinal tract21 and microbial 
fermentation also occurs mainly in the colon. 
Figure 1. Density and composition of the human gut microbiota. Microbial concentrations 
(represented as microorganisms per gram for each section of the gastrointestinal tract) 
increase towards the lower gastrointestinal tract with highest concentrations found in the 
colon. Adapted from (Leser and Molbak, 2009)
However, sampling from colonic microbiota is not possible without invasive approaches22 
and therefore most of the studies focusing on the gut microbiota of humans have been 
performed on faecal samples. Studies, mostly performed in adults, have revealed that the 
gut microbiota in an average healthy human is dominated by bacterial species belonging 
to two major phyla; Bacteriodetes (gram-negative) and Firmicutes (gram-positive), and 
to a lesser extent by microorganisms from the phyla Actinobacteria, Proteobacteria, 
and Verrucomicrobia.23,24 Next to bacteria, the microbiota also consists of eukaryotic 
microorganisms and archaea. The archaea are a separate domain of prokaryotic 
microorganisms that are different from the prokaryotic eubacteria as well as from the 
eukaryotes, although recent insights indicate that eukaryotes are best classified within 
the archaea rather than being a separate branch of the evolutionary tree.25 In contrast 
to the many bacterial species, only three archaeal species: Methanobrevibacter smithii,26 
Methanosphaera stadtmanae27 and Methanomassiliicoccus luminyensis,28 all belonging to 
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the phylum Euryachaeota, have been recovered from the human GI tract. Together 
these microorganisms live in a symbiotic relationship with and exert multiple health 
beneficial functions for its host. These functions include the prevention of colonization 
of the intestinal lumen by pathogenic bacteria (so called colonization resistance), 
maturation of the intestine, metabolic functions (i.e. the breaking down of indigestible 
food particles and synthesis of short-chain fatty acids and micronutrients) and immune 
modulation and regulation.29 30 
Development and determinants of the Gut Microbiota
As indicated by several recent studies, microbial colonization of the intestinal tract might 
already start before birth by microbial transfer through the placenta.31-33 However, it is 
only during and upon birth, when the infant is exposed to a wide variety of parental 
and environmental bacteria and massive colonization starts. During the first year of life 
the infant intestinal tract subsequently becomes progressively colonized with a mixture 
and high density of microbes. By the age of 2 to 3 years an adult-like microbiota has 
established34-37, although maturation of the microbiota may still continue for several 
years. The developmental process of the infant microbiota is mainly influenced by 
factors such as mode of delivery, type of infant feeding and antibiotic use (Figure 2).38-41 
Short-term treatment in humans with a single dose of oral antibiotics can dramatically 
affect the gut microbiota composition, although it then tends to revert to its original 
composition within several weeks or months.42 
The final gut microbiota composition is then influenced by colonization history, host 
physiology, environmental factors,43 and host genetic make-up.43-46 19 
Figure 2. A representation of factors influencing microbiota transmission, maturation and 
perturbation in the first years of life and possible effects on weight. Data taken from (Cox & 
Blaser, 2014)
The gut microbiota of individuals from the same household are more similar compared 
to those from a different household.34 In addition, the microbiota of monozygotic twins 
living apart, have been reported to be more similar than the microbiota of unrelated 
individuals.44 Also, recent studies have shown that the composition of the gut microbiota 
is altered in overweight/obesity leading to a reduction in both microbial diversity and 
richness.23,47-50
Gut microbiota and obesity
The composition of the gut microbiota during early life has been suggested to be 
associated with childhood overweight/obesity.51 Changes in the ratio of the major phyla 
Firmicutes and Bacteroidetes as well as specific bacterial groups have previously been 
associated with obesity (reviewed in18). However, there has been a lack of a consensus 
between studies with regards to the direction of these associations where some studies 
reported a positive52,53, while other reported a negative44,54-58 or no association47,59-63 
between either the Bacteroidetes to Firmicutes ratio or specific bacterial groups (e.g. 
Bacteroides fragilis,25 Bifidobacterium spp, Staphylococcus spp,26 Akkermansia muciniphila27 
and Faecalibacterium prausnitzii)20 or archaeal species (e.g. Methanobrevibacter smithii)28 
Additionally some, but not all studies reported a lower microbial richness (counts of 
unique bacterial groups present in the gut) and/or diversity (counts of unique bacterial 
groups while taking into account their relative abundances) in obese as compared to 
lean subjects49,58,64. In this regards, the exact role of the gut microbiota in human obesity 
still remains unclear. The lack of consensus may be explained by the fact that studies 
done in rodent models have their limitations in terms of gut microbiota composition, 
fermentation process (e.g. location) and dietary practices (coprophagia).65,66 With regards 
to studies in humans, this is likely due to differences of the gut microbiota composition 
between individuals, different methods used for DNA isolation and microbial analysis, 
geographical location, diet, and ethnicity. Although convincing in mouse models, it 
remains difficult to conclude whether disturbances in gut microbiota are cause or just 
consequence of obesity in humans. Transplantations of gut microbiota from lean or obese 
mice to germ-free recipients have revealed that the obesity phenotype is transferable by 
the microbiota. Hence, gut microbiota from genetically obese and diet-induced obese 
mice are capable of causing obesity in recipients.67,68 Interestingly, there seems to be a 
similar causal relationship in humans. There has been a case-study of a woman who 
suffered from recurrent Clostridium difficile infection and was successfully treated with 
faecal microbiota transplantation, but later on developed obesity after receiving the 
stool transplant from a healthy but overweight donor.69 Furthermore, transplantation of 
intestinal microbiota from lean donors to recipients suffering from metabolic syndrome 
resulted in improved glucose metabolism and insulin sensitivity together with increased 
levels of butyrate-producing bacteria.70
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Mechanism of action of gut microbiota in weight development
Dysbiosis, an imbalance in the composition of the intestinal bacteria, may lead to 
obesity via several proposed mechanisms. The obesity-associated microbiome might 
have an increased capacity to harvest energy from the diet due to the more efficient 
breakdown of dietary non-digestible carbohydrates to short chain fatty acids (SCFA) 
such as acetate, propionate and butyrate (Figure 3) that serve as an energy source for 
the host.68 Methanogenic microorganisms use hydrogen, a by-product of bacterial 
fermentation, to produce methane. The removal of hydrogen accelerates the bacterial 
fermentation of polysaccharides and other carbohydrates, leading to the more efficient 
production of short-chain fatty acids.68,71-74
Another proposed mechanism is that, the gut microbiota interplays with the signalling 
and regulatory network of the host and thereby regulates the energy balance. It has been 
shown that the gut microbiota promotes monosaccharide absorption and regulates the 
expression of the fasting-induced adipocyte factor (FIAF) in the intestinal tissue, which 
is an inhibitor of lipoprotein lipase (LPL). The modification of the gut microbiota 
causes a decrease in the expression of FIAF resulting in increased lipase activity which 
in turn promotes increased uptake of fatty acids and triacylglycerol accumulation in 
adipocytes.75,76 In addition, SCFAs play a signalling role by binding on the G-protein-
coupled receptors, Gpr41 and Gpr4377,78 stimulating a cascade which leads to increased 
fat storage and energy preservation. A study in Gpr41 deficient mice (which are leaner 
than their wild type littermates) suggested that activation of Gpr41 by SCFA was 
responsible for the production of Peptide YY (PYY) that conveys a sense of “fullness” 
and regulates appetite.79,80 This was because the Gpr41 deficient mice have lower 
expression of PYY (a gut derived hormone responsible for slowing down gastrointestinal 
transit). The elimination of Gpr41 from these mice which were being fed with high-
carbohydrate, high-fat diet resulted in reduced levels of PYY and increased gut transit 
rates, resulting in more energy being lost with faeces compared with their wild-type 
littermates.77 
Consumption of a high-fat diet can also lead to alteration of the gut microbiota 
composition in such a way that it negatively impacts the gut barrier. The increased 
permeability of the gut may subsequently lead to the translocation of harmful substances 
such as lipopolysaccharide (LPS, a component of the cell wall of gram-negative bacteria) 
from the intestinal lumen to the circulation, resulting in metabolic endotoxemia.81-86 
LPS can bind to TLR4/CD14 receptors leading to the production of cytokines such as 
TNF-alpha and IL-6, which are involved in the development of obesity. In addition, 
LPS molecules can also stimulate adipogenesis by stimulating CB
1 
receptors, which are 
responsible for the activation of the endocannabinoid system.44,84 
The KOALA Birth Cohort Study
The KOALA Birth Cohort Study aims at identifying factors that influence the 
development of allergic diseases as well as weight development with a main focus on 
lifestyle (e.g. anthroposophy, vaccinations, antibiotics, and dietary habits), breastfeeding 
and breast milk composition, intestinal microbiota composition, infections during first 
year of life, and gene-environment interactions. From October 2000 until December 
2002, a total of 2834 pregnant women were recruited at 34 weeks of gestation. 
Pregnant women with a conventional lifestyle (n=2343) were recruited from an 
ongoing prospective cohort study (n=7020) on pregnancy-related pelvic girdle pain in 
the Netherlands.87 A second group of pregnant women (n=491) was recruited through 
alternative channels, organic food shops, Steiner schools, magazines and anthroposophic 
doctors and midwives. Information of other relevant variables were first obtained from 
the pregnant mothers and covered the first and third trimester as well as early childhood. 
This was done through the use of repeated questionnaires at 14-18, 30, and 34 weeks of 
gestation and 3, 7, 12, and 24 months post-partum. Physical activity and dietary intake 
(using food frequency questionnaires (FFQ) were obtained from the children at 4-5 
Figure 3. An overview of metabolism by the gut microbiota. Gut microbiota converts 
polysaccharides into monosaccharides, short-chain fatty acids and other end products. The 
binding of SCFAs to two G-protein-coupled receptors (GPR41 and GPR4) activates them to 
induce the production of peptide YY. Data obtained from (Moreno-Indias et al, 2014)88 
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years of age. A subgroup of participants, including both conventional and alternative 
lifestyles, was asked to give their consent to maternal blood sampling during pregnancy, 
maternal breast milk collection, collection of a faecal sample of the child at one month 
post-partum and 6-7 years of age, capillary blood at age 1 year, and venous blood at 2 
and 6-7 years. 
Additionally, anthropometric variables (such as height, and weight) were obtained from 
the children at different follow-up points through the use of questionnaires filled out 
by the parents and during home visits at 6-7 years of age by trained nurses. The parents 
were asked to measure and report the child’s height (cm) and weight (kg, specified to 
one decimal) without clothes or shoes at ages 0-1, 2-3, 4-5, 6-7, 7-8, 8-9, and 9-10 years 
respectively (Figure 4) 
Aim and outline of the thesis
The main aims of this thesis were to: 1) examine associations between the gut microbiota 
composition and childhood (over)weight development; 2) examine the impact of 
childhood exposure to oral antibiotics and (over)weight development; and 3) address 
the methodological challenge of reducing high dimensional data of the gut microbiota 
in relation to latent BMI z-scores trajectories. To address these aims, a combination 
of advanced molecular microbial methods, a well-designed prospective epidemiological 
study and state-of-the-art biostatistical methods were used.
Chapter 2 of this thesis presents a study on the association between the infant gut 
microbiota composition at one month of age as determined by real-time PCR, and 
the development of childhood overweight using anthropometric measures (weight- 
and BMI z-score, and overweight) over a period of ten years. Generalised estimation 
equations were used to take into account correlations between repeated anthropometric 
measurements within children. Chapter 3 examines the gut microbiota of children at 
the age of 6-7 years in association childhood overweight. At this age the microbiota is 
assumed to be more stable, resilient and adult-like. In addition, instead of measuring 
a few species of the gut microbiota, a broad, high-resolution interrogation of the 
entire gut microbial community using the Human Intestinal Tract Chip (HITChip) 
was performed. Advanced statistical methods (Elastic net, and Redundancy data 
analysis (RDA)) were then applied for both the reduction of the high dimensionality 
data obtained and investigating the association of the gut microbiota with childhood 
body weight. In chapter 4, we identified the presence of two species of archaea, 
Methanobrevibacter smithii, and Methanosphaerae stadtmanae, in the faecal samples of 
472 children at 6-7 years of age using real-time qPCR assays. After identification of 
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these archaea, their associations with childhood weight development from 6 – 10 years 
of age were investigated. 
There is evidence suggesting that oral administration of antibiotics may lead to 
childhood overweight, through modulation of the composition of the normal healthy 
gut microbiota. The work presented in chapter 5 was aimed at examining the association 
between childhood exposure to oral antibiotics (including the timing, frequency and 
type) over a period of 0 – 10 years in relation to anthropometric outcomes (weight- 
height- and BMI z-scores) measured repeatedly over this period. 
Group-based trajectory modelling (GBTM) was used to delineate and visualize distinct 
childhood weight developmental patterns (BMI z-scores trajectories) from 6 to 10 
years of age. Data from the gut microbiota was then used to investigate if there exist 
potential bacterial group candidates that could be used to differentiate these BMI 
z-score trajectories (chapter 6). The final chapter, chapter 7, summarises and discusses 
the findings of this thesis and provides recommendations for future research.
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Abstract 
Objective To investigate whether the intestinal microbiota composition in early infancy 
is associated with subsequent weight development in children.
Methods Analyses were conducted within the KOALA Birth Cohort Study (n=2834). 
This cohort originates from two recruitments groups, pregnant women with a 
conventional lifestyle (no selection based on lifestyle) and pregnant women recruited 
through alternative channels (organic shops, anthroposophic clinicians/midwives, 
Steiner schools, and relevant magazines). From 909 one-month-old infants fecal samples 
were collected and analyzed by qPCR targeting bifidobacteria, Bacteroides fragilis-group, 
Clostridium difficile, Escherichia coli, lactobacilli, and total bacteria counts. Between the 
ages of 1-10 years, parent-reported weight and height was collected at 7 time points. 
Age- and gender-standardized Body Mass Index (BMI) z-scores were calculated. Data 
were analyzed using Generalized Estimating Equation.
Results Colonization with B. fragilis-group was borderline significantly associated with 
a higher BMI z-score of 0.15 (95% CI: -0.02 to 0.31), in the conventional subcohort. 
After stratification for fiber intake (p
forinteraction
 0.003), colonization with B. fragilis-group 
was associated with a 0.34 higher BMI z-score among children with a low fiber intake 
in this subcohort (95% CI: 0.17 to 0.53). Higher counts among colonized children 
were positively associated with BMI z-score only in children within the conventional 
subcohort and a high fiber diet (BMI z-score 0.08; 95% CI: 0.01 to 0.14), but inversely 
associated in children with a low fiber diet (BMI z-score -0.05; 95% CI: -0.10 to 0.00), 
and in children recruited through alternative channels (BMI z-score -0.10; 95% CI: 
-0.17 to -0.03). The other bacteria were not associated with BMI z-scores, regardless of 
subcohort. 
Conclusion Using a targeted approach, we conclude that the intestinal microbiota, 
particularly the B. fragilis-group, is associated with childhood weight development. To 
identify the potential impact of additional bacterial taxa, further prospective studies 
applying an unconstrained in-depth characterization of the microbiota are needed.
Introduction
Overweight and obesity can have serious health consequences, including type 2 diabetes 
and cardiovascular diseases, which are major public health problems1. Not only in 
adults, but also in children, the prevalence of overweight and obesity is increasing2, 3. The 
development of obesity is a complex process involving both genetic and environmental 
factors, such as an increased energy intake and reduced energy expenditure. However, 
these factors do not fully explain the increased obesity prevalence4, 5.
Our human gut is colonized with a complex 100 trillion microbe cells, the intestinal 
microbiota. The intestinal microbiota composition varies between individuals; the 
development of the infant microbiota is mainly influenced by prenatal exposure: 
mode of delivery, type of infant feeding, and antibiotic use6. Recently, the intestinal 
microbiota has been identified as a potential determinant of obesity, both in animal and 
human studies. The study by Ley et al. published in 2005, showed for the first time that 
the intestinal microbiota differs between lean versus obese mice7. Obese mice harbor 
significantly less Bacteroidetes and more Firmicutes compared to their lean siblings7. 
Furthermore, colonization of germ-free mice with an intestinal microbiota of obese 
donor mice led to a significantly greater increase in fat deposition than colonization 
with an intestinal microbiota of lean donors8. A limited number of human studies, 
usually comparing obese with normal weight subjects in a cross-sectional design, have 
been conducted so far. In addition, the many different methods for characterization of 
the indigenous microbiota complicate the direct comparison of results between studies 
(summarized in Table 1). So far, studies have provided contradictory results: some 
demonstrated a reduced level of Bacteroidetes to be associated with obesity9-14, whereas 
others found the opposite15-17, or no association18-22. Specific bacterial and archeal genera 
or species have also been associated with obesity in humans, such as, the Lactobacillus 
spp10, 22, 23, bifidobacteria15, 24, 25, Escherichia coli25, and Methanobrevibacter smithii10, 15, 
23 (Table 1), but findings were not consistent between studies. To determine whether 
a different microbiota composition in early infancy is related to subsequent weight 
development, longitudinal cohort studies are needed. To our knowledge only four 
human observational studies investigated the relation between intestinal microbiota 
composition and weight development in a longitudinal manner25-29, two of which 
addressed microbiota in infancy with short term follow-up but not beyond infancy28, 
29 and two others addressed microbiota at ages 6-12 months and 3 months, in children 
with follow-up until 7 years and 10 years, respectively25-27 (Table 1).
Several mechanisms have been put forward to explain how the interaction between 
microbiota and host metabolism may contribute to obesity30, 31. Certain species are able 
to digest dietary fiber, i.e. complex carbohydrates that cannot be degraded by human 
enzymes, thus yielding energy for microbial growth and end products such as short-chain 
fatty acids (SCFAs). The latter have profound effects on human metabolism because 
they can serve as energy substrates for the gut (butyrate) and peripheral tissues (acetate, 
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propionate), modulate inflammation and wound healing, and act as vasodilators30, 31. 
In addition, SCFAs can signal through G-protein−coupled receptors (GPRs), such as 
GPR41, on enteroendocrine cells, inducing the secretion of peptide YY32, 33.
The aim of this study was to investigate whether the intestinal microbiota composition in 
early infancy is associated with subsequent weight development during childhood. The 
fecal samples of 909 one-month-old infants were analyzed with quantitative polymerase 
chain reaction (qPCR) assays, to enumerate several bacterial groups and species and 
related to weight development up to the age of 10 years.
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Methods
Subjects and Study Design
The current analyses were conducted within the KOALA Birth Cohort Study in the 
Netherlands. The design of the KOALA study has been described in detail elsewhere34. 
Briefly, this cohort originates from two recruitment groups, healthy pregnant women 
with a conventional lifestyle (n=2343) and pregnant women recruited through 
alternative channels (n=491). The women with a conventional lifestyle were retrieved 
from an on-going prospective pregnancy cohort study on pregnancy-related pelvic girdle 
pain in the Netherlands35. The second group of pregnant women were recruited through 
alternative channels, i.e. posters in organic food shops, anthroposophic doctors and 
midwives, anthroposophic under-five clinics, Rudolf Steiner schools, and magazines for 
special interest groups. This latter group of women was considered to have an alternative 
lifestyle, which could involve dietary habits (vegetarian, organic), child rearing practices, 
vaccination schemes and/or use of antibiotics. All participants were enrolled at 34 weeks 
of gestation.
Women recruited from January 2002 until December 2002 (n=1176) collected a fecal 
sample from their child approximately one month postpartum. Inclusion criteria for the 
present analyses were: availability of a fecal sample collected between 3 and 6 weeks of 
life, sufficient amount of feces (≥ 1 g), and parental completion of the accompanying 
questionnaire (fecal collection questionnaire).
Exclusion criteria were: prematurity (infants born before 37 weeks of gestation), twins, 
congenital abnormalities related to growth (such as Down’s syndrome, Turner syndrome, 
Fallot’s tetralogy multiple disabilities), administration of antimicrobial agents before feces 
collection, and children without any BMI measurement (Figure 1). All parents signed 
the informed consent and the study was approved by the Medical Ethics Committee of 
Maastricht University Medical Center+ (Maastricht UMC+).
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FIGURE 1. Flow chart of the study population. The KOALA Birth Cohort study included 
pregnant women with a conventional lifestyle (recruited from the on-going Pregnancy-
related Pelvic Girdle Pain study (PPGP)) or an alternative lifestyle (recruited from 
‘alternative’ channels). Participants recruited from January 2002 onwards were asked to 
collect a fecal sample of their child. Reasons for exclusion with numbers, and response rates 
on the seven weight and height questionnaires are presented.
Fecal collection and Microbial analysis
Parents were asked to collect the feces of their child at one month postpartum. They 
received a feces tube with a spoon attached to the lid (Sarstedt, Nümbrecht, Germany), 
together with a sanitary napkin, an instruction form about the correct collection and 
sending procedure, and a brief questionnaire. Parents placed a sanitary napkin in the 
diaper to prevent absorption by the diaper; collection of the feces was done by spoon 
and deposited in the tube. The tube was sent to the Medical Microbiology department 
at Maastricht UMC+ by post as soon as possible. Transport time was minimized by 
asking the parents to collect the feces on a Monday, Tuesday or Wednesday, so that the 
samples did not remain in the mail over the weekend.
At the laboratory, fecal samples were 10-fold diluted in peptone-water (Oxoid CM009) 
containing 20% v/v glycerol (Merck, Darmstadt, Germany) and stored at -20˚C until 
analysis.
DNA extraction from the feces and the subsequent microbial analyses by means of 
real-time PCR assays has been described in detail elsewhere6. Briefly, the DNA was 
extracted by a combination of bead-beating and the QIAamp DNA Stool Mini Kit 
(Qiagen, Hilden, Germany). DNA from all fecal samples was subjected to real-time 
PCRs for quantification of bifidobacteria, Bacteroides fragilis group, Clostridium difficile, 
Escherichia coli, lactobacilli, and total bacteria based on 16S rDNA gene sequences. 
For detection of the bifidobacteria, C. difficile, E. coli, and members of the bacteroides, 
the 5’-nuclease technique was used. For quantification of lactobacilli and total bacteria 
load, real-time detection of PCR products was conducted by means of SYBR Green 
I (Bio-Rad Laboratories, Hercules, CA). The validation of the real-time PCR assays 
has been described in detail elsewhere36-38. Log
10
 colony-forming units per gram (log
10 
CFU/g) were calculated for each stool sample from the threshold cycle values by using 
the constructed standard curves. The prevalence of colonization was expressed as the 
percentage of infants colonized with a specific bacterial group or species. Since almost 
all infants were colonized with bifidobacteria, a cut-off value of 10.68 log
10
 CFU/g (the 
median) was used to divide the population into those with a low or high abundance of 
the genus.
Outcome variable
Information on the child’s weight, height and age at the time of measurements was 
collected using self-administered questionnaires. Parents were asked to report their 
child’s body weight and height at 7 different time points. At the first and second time 
points, where the children had an average age ± standard deviation (SD) of 11 ± 1 
months and 22 ± 3 months, respectively, parents were asked to report the most recent 
weight and height measured at the child health clinic, and to also report the age (in 
months) at the time of these measurements. At the further follow-up time points, in 
2006 (age 56 ± 4 months), 2007 (age 73 ± 5 months), 2008 (age 80 ± 5 months), 2009 
35 
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(age 92 ± 5 months), and 2010 (age 103 ± 5 months), parents were asked to measure 
weight (in kilograms specified to one decimal) and height (in centimeters) without shoes 
and clothes and to report the exact date of measurement. BMI (weight/height2, kg/m2) 
was standardized by recoding it into age- and gender specific BMI z-scores using data 
from the Dutch reference population39.
Statistical analysis
The characteristics of the participants are given as mean values ± SD for continuous 
variables and as numbers and proportions for categorical variables. Missing values for 
continuous covariables were replaced with the mean (maternal pre-pregnancy BMI n=2, 
age at collection of fecal sample n=10), and missing values for categorical covariables 
were classified as ‘unknown’ (place and mode of delivery n=23, maternal education of 
the mother n=10). 
Generalized Estimating Equation (GEE) models with unstructured correlation structure 
were used for analysis of the repeated BMI z-scores. The analyses included only one 
bacterial group or species at a time. When bacterial counts were used as an independent 
variable, only infants who were colonized with that specific bacterial group or species 
were included. The age of the child at the time of BMI measurement was included 
in all models as the time variable. We tested if the association between the intestinal 
microbiota composition and BMI z-scores differed with increasing age by including an 
interaction term in the GEE models. When the interaction term was significant (p-value 
< 0.05), we performed linear regression analyses for each BMI measurement separately. 
Participants were recruited through two different recruitment channels (representing 
a conventional or alternative lifestyle); we therefore tested for interaction between the 
intestinal microbiota and recruitment group. The interaction term was significant for 
C. difficile (p 0.037) and B. fragilis-group (p 0.032); we therefore performed all analyses 
stratified for lifestyle.
First, unadjusted GEE analyses were performed to determine the association between 
colonization (yes/no) and bacterial counts (log
10
 CFU/g), and BMI z-scores. Second, 
adjusted GEE analyses were conducted that included potential confounders. If the 
potential confounder changed the regression coefficient of any of the main determinants 
by more than 10%, it was consequently included in all models. The following variables 
were considered: infant gender (male, female), place and mode of delivery (vaginal 
delivery at home, vaginal delivery in hospital, artificial delivery in hospital, caesarean 
section in hospital), birth weight (grams), maternal pre-pregnancy BMI (kg/m2), age 
at collection of fecal sampling (in days), maternal smoking during pregnancy (number 
of cigarettes per day), type of infant feeding in the first month (exclusive breastfeeding, 
exclusive bottle-feeding, or a combination), duration of breastfeeding (months), 
education level of the mother (lower education, vocational education, higher general 
secondary/pre-university, or higher vocational/academic education), and total counts of 
bacteria. Finally, a third model additionally included the following dietary variables: total 
energy intake, energy percentage from fat, and energy percentage from protein. Dietary 
information was collected during a period of 4 weeks by a food frequency questionnaire 
(FFQ) administered at the age of 4 years. The questionnaire was specifically developed to 
assess children’s energy intake and validated by using the doubly labeled water method40. 
The questionnaire consisted of 71 items, and, in addition, for 27 foods the specific types 
or brands consumed and preparation methods were asked. Parents reported their child’s 
habitual food consumption by indicating the frequency of consumption (‘never’ to ‘6-7 
days a week’) and by specifying proportion sizes in natural units (e.g., pieces, slices), 
household units (e.g., glasses of spoons) or grams (e.g., grams of fish). Parents were 
asked to measure volume of the cups and glasses they used for the children. The average 
energy intake (kJ) and fiber intake (in grams per MJ) per day were calculated using the 
Netherlands Food Composition Table 2001 (NEVO)41. For the products that were not 
included in the NEVO 2001 table the nutritional values were provided by a dietician. 
Fiber intake was considered as a potential effect-modifier. Information on dietary fiber 
intake at the age of 4 years was also obtained from the FFQ. To determine whether 
dietary fiber modified the associations between the intestinal microbiota and weight 
development, a test for interaction with fiber intake was conducted in both recruitment 
groups. If the interaction term was significant, the analysis was stratified by level of 
dietary fiber intake (above or below the median of 15.0 g/day). 
Data analysis was performed using the SPSS statistical software package version 19.0 
(SPSS Inc., Chicago, IL, USA). The unadjusted (crudeβ) and adjusted (adjβ) regression 
coefficients with the corresponding 95% confidence interval (95% CI) are presented. A 
p-value of < 0.05 was considered statistically significant in all analyses.
Results
Of the 1176 collected fecal samples, the samples that were too small (<1 g) (n=65), 
were collected before the age of 3 weeks or after the age of 6 weeks (n=54), or where 
the fecal questionnaire was missing (n=25) were excluded. In total 1032 fecal samples 
were appropriate for microbial analysis6. After exclusion of premature infants (n=2), 
twins (n=10), children with congenital abnormalities related to growth (n=6), children 
without any BMI measurement (n=18), and children who received antibiotics prior to 
fecal sampling (n=95), the study population consisted of 909 children (Fig 1). Table 
2 shows the baseline characteristics of the KOALA cohort (n=2834) and the study 
population (n=909). In general, the two groups were comparable, except that the study 
population had more participants with an alternative lifestyle, a higher level of maternal 
education, and longer duration of breastfeeding, but less mothers who smoked during 
pregnancy. These differences are mainly due to the period of fecal sampling, which 
coincided with recruitment of the alternative group. Almost all infants were colonized 
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with bifidobacteria (98.6%), followed by E. coli (88.2%), and B. fragilis-group (81.2%), 
whereas colonization with C. difficile (25.3%) and lactobacilli (31.9%) was less frequent 
(Table 2).
TABLE 2 Baseline characteristics of the KOALA Birth Cohort and the study population
 KOALA Birth 
Cohort Study
Study population 
(n = 2834) (n = 909)
Determinants   
Prevalence of colonization with intestinal bacteria, n (%)
Bifidobacteria - 896 (98.6)
Escherichia coli - 802 (88.2)
Clostridium difficile - 230 (25.3)
Bacteroides fragilis group - 738 (81.2)
Lactobacilli - 290 (31.9)
Counts of intestinal bacteria (log
10
 CFU/g), median (range) §
Bifidobacteria - 10.69 (6.84 – 11.56)
Escherichia coli - 9.30 (5.91 – 10.79)
Clostridium difficile - 5.40 (2.70 – 9.57)
Bacteroides fragilis group - 9.40 (5.74 – 10.36)
Lactobacilli - 8.66 (7.92 – 10.73)
Total count - 12.69 (8.47 – 19.63)
Covariables 
Age sampling feces (days), (mean ± SD) - 31.7 ± 3.3
Recruitment group conventional 2343 (83%) 618 (68%)
Maternal education *
Low 289 (10%) 60 (7%)
Middle 1060 (38%) 312 (34%)
High 1341 (48%) 508 (56%)
Other 108 (4%) 19 (2%)
Maternal pre-pregnancy BMI (kg/m2), (mean ± SD) 23.6 ± 4.0 23.3 ± 3.6
Maternal smoking during late pregnancy
Yes 200 (7%) 27 (3%)
Gender
Boy 1451 (51%) 454 (50%)
Birth weight, gram (mean ± SD) 3500 ± 512 3562 ± 467 
< 2500 79 (3%) 12 (1%)
2500 – 4500 2663 (95%) 873 (96%)
> 4500 70 (3%) 24 (3%)
Place and mode of delivery
Natural delivery at home 1187 (42%) 432 (48%)
Natural delivery in hospital 924 (33%) 301 (33%)
Artificial delivery at home† 2 (0%)
Artificial delivery in hospital† 223 (8%) 66 (7%)
Caesarean section in hospital 311 (11%) 93 (10%)
Duration of breastfeeding, months (mean ± SD ) 4.7 ± 3.0 5.9 ± 4.5 
Type of infant feeding
Formula feeding from birth 446 (16%) 113 (12%)
Combination of breast and formula feeding in first 3 months 1185 (42%) 320 (35%)
Breastfeeding as the only milk feeding in first 3 months 614 (22%) 241 (26%)
Breastfeeding as the only milk feeding in first 6 months 562 (20%) 235 (26%)
Dietary factors 
Total energy intake, kcal (mean ± SD) 1466 ± 305 1445 ± 298 
Energy percentage from fat, % (mean ± SD) 14.6 ± 2.1 14.4 ± 2.1
Energy percentage from protein, % (mean ± SD) 29.6 ± 4.2 29.4 ± 4.3
Energy percentage from carbohydrates, % (mean ± SD) 55.8 ± 5.0 56.1 ± 5.1
Fiber, gram (mean ± SD) 15.3 ± 4.0 15.4 ± 4.1
Numbers do not always add up to the total because of missing data.
§ Includes only children who were colonized with the specific bacteria group or species.
* Low: primary school, preparatory vocational or lower general secondary school, middle: vocational, higher general 
secondary or pre-university education, high: higher vocational or academic education.
† Forceps or vacuum extraction.
Neonatal colonization with B. fragilis-group in the conventional subcohort was associated 
with a statistically significant higher BMI z-score of 0.16, compared to infants who were 
not colonized (Table 3). However, this did not remain significant after adjustment (Adjβ 
0.11; 95% CI -0.05 to 0.26). Other bacterial groups or species were not associated 
with BMI z-scores in children in the conventional subcohort. In children, from the 
alternative subcohort (Table 4), a higher count of B. fragilis-group was associated with a 
significantly lower BMI z-score in both crude and adjusted models (Adjβ -0.07; 95% CI 
-0.15 to 0.00). Other bacterial groups or species were not associated with BMI z-scores 
in the alternative subcohort. 
In the conventional subcohort, the interaction term between colonization with B. 
fragilis-group and fiber intake was significant (p 0.003). 
Table 2. (cont.)
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There was no significant interaction with fiber for any of the other bacteria. After 
stratification for fiber intake (Table 5), in children with a lower than median fiber 
intake (<15 g/day), colonization with B. fragilis-group was associated with a higher BMI 
z-score (Adjβ 0.34; 95% CI 0.17 to 0.53), however higher counts of B. fragilis-group 
in colonized children was associated with a lower BMI z-score after adjustment for 
potential confounders (Adjβ -0.05; 95% CI -0.10 to 0.01). Furthermore, in children 
with a higher than median fiber intake (>15 g/day), colonization with B. fragilis-group 
was not associated with BMI z-scores, but a higher count of B. fragilis-group was 
associated with a higher BMI z-score (Adjβ 0.07; 95% CI 0.01 to 0.14). For all analyses, 
adding the dietary variables to the adjusted models (model 3) did not substantially alter 
the results.
Finally, we examined whether associations of bacterial groups and species with BMI 
z-scores changed over time (age of BMI measurement). Only for C. difficile the time 
interaction term was significant (p 0.002). Linear regression analysis showed that 
children in the conventional subcohort, who were colonized with C. difficile at one 
month postpartum, had a lower BMI z-score of -0.24 (Adjβ 0.24; 95% CI -0.45 to 
-0.03) at 103 ± 5 months of age. For the other time points, no significant effects were 
found (data not shown).
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Discussion
The current study showed that colonization with B. fragilis-group at one month 
postpartum tended to be associated with a higher BMI in children up to 10 years of 
age, in particular among children in the conventional subcohort and a low fiber diet. In 
line with our results, Bäckhed et al. showed that host total body fat content increased 
after colonization of germ free mice with Bacteroides thetaiotaomicron, the most 
abundant member of the B. fragilis-group in the human gut42. These latter results were 
explained by the ability of Bacteroides thetaiotaomicron to ferment plant- or host-derived 
polysaccharides to SCFAs, in particular acetate. Acetate can serve as a source of energy 
for peripheral tissues, and is taken up by the liver and used as a substrate for lipogenesis 
and gluconeogenesis. Colonized mice have higher levels of liver triglycerides, which 
suppress the expression of fasting induced adipose factor (FIAF) and increases the storage 
of triglycerides in adipocytes30, 31. Our results are furthermore in accordance with the 
observational study by Vael et al., who showed a positive association between B. fragilis-
group in the feces of 3- and 26-week old infants, and BMI z-score at preschool age (up 
to 36 months) (n=138)28. In contrast to our study, White et al. showed that presence of 
Bacteroides spp. in 30-day old infants was associated with lower body weight z-scores at 
the age of 6 months in males (n=108), but not in females29. However, these studies used 
traditional culture and a microarray respectively to assess the microbiota composition, 
caution is therefore required when comparing these results with our study. The role of 
fiber in children colonized with members of the B. fragilis-group is contradictory. Only 
in children with a low fiber diet (<15 g/day) colonization with B. fragilis-group resulted 
in a higher BMI. In children with a high fiber diet colonization with B. fragilis-group 
did not influence BMI. A potential explanation for this loss of association between 
colonization with the B. fragilis-group and BMI in the high fiber consumers might be 
that consuming a high fiber diet at the age of 4 years might compensate for the effect 
that early B. fragilis-group colonization has on BMI. 
Our results for higher counts of B. fragilis-group in children who are colonized, are 
less clear. Higher counts are positively associated with BMI only in children in the 
conventional subcohort and a high fiber diet, but inversely associated in children with 
a low fiber diet, and in children in the alternative subcohort. A plausible explanation 
might be a different composition of B. fragilis-group species between infants in the 
two different recruitments groups. The pregnant women recruited through alternative 
channels, might introduce a different lifestyle for their children promoting early 
colonization with other bacteroides species than in the conventional subgroup. Indeed, 
species within the B. fragilis group might differentially affect weight development as 
suggested by Bervoets et al. who showed more B. fragilis in obese and more B. vulgatus 
in control subjects. Identification of bacteroides at the species level in future prospective 
studies is warranted to address whether a different species distribution actually precedes 
(over)weight development during childhood.
We are not aware of any previous human studies that investigated the interaction between 
bacteroides and dietary fiber intake. It is important to note that although we were able to 
study this interaction, collection of fecal samples (at 1 month) and dietary information 
(at 4 years) did not take place at the same time, and this is clearly a weakness of this study. 
Despite the high instability of the microbiota in infancy, it may be speculated that the 
presence of B. fragilis-group as pioneer species in the neonatal gut could be indicative for 
the subsequent persistence of these bacteria or other developmental processes towards 
an adult-like microbiota. Although, dietary information was only collected once, at the 
age of four years, we used a validated FFQ to determine the habitual dietary intake. The 
FFQ reflects the long-term dietary pattern and gives a much better estimate of habitual 
dietary intake than instruments such as food diaries and 24-hour recall. In addition, 
previous studies showed that dietary patterns stay relatively stable during childhood43, 44.
Furthermore, we observed that neonatal colonization with C. difficile was associated 
with a lower BMI at the age of 103 ± 5 months. Since, asymptomatic carriage of C. 
difficile is very common in the first years of life and a significant effect was only found in 
the children in the conventional subcohort, after adjustment of potential confounders, 
and merely in the last time point of BMI measurement (average age of 105 months), 
caution in drawing conclusions is required. Since we conducted several tests for the 
5 different bacteria groups/species, a type I error due to multiple testing cannot be 
excluded. Therefore, further research is required to replicate our findings.
We did not find an association between bifidobacteria and BMI development. This 
is in contrast to the results from Kalliomäki and colleagues26, who found lower levels 
of bifidobacteria at 6 and 12 months of age in children with normal weight (n=24) 
compared to overweight or obesity (n=25) at 7 years of age. That study was the first to 
show an association between the intestinal microbiota composition and the development 
of overweight. We did not find an association between bifidobacteria and subsequent 
BMI in children. In our study, fecal samples were collected only at age 1 month when 
almost all children are colonized with high concentrations of bifidobacteria, which 
might mask a potential effect of bifidobacteria. 
The prospective study design, a large study population, adjustment for the main 
determinants of the microbiota composition in early infancy (for example, place and 
mode of delivery, type of infant feeding in the first month), and repeated measurements 
of BMI on 7 occasions over a time period of 10 years are major strengths of our study. 
Nevertheless, the present study has also some limitations; one drawback is that only five 
bacterial groups and genera were measured, while others may also be involved in weight 
development in childhood45. Previous studies using extensive profiling of the neonatal 
gut microbiota, have however shown that the microbiota at this age is still very simple 
and dominated by the bacterial groups targeted in the present study46. Another drawback 
of this study was the timing of fecal sampling collection at 1 month of age. In early 
infancy, the gut microbiota composition is relatively unstable and its role in shaping the 
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microbiota at a later age is to date unknown47, 48. This study only provides information 
on the role of the intestinal microbiota at early infancy. The measured species might 
actually indicate presence or absence of other unstudied co-occurring bacterial genera 
or species that influence weight development49. Another limitation relates to the time 
between collection of the fecal sampling by the parents and analyzing the samples in the 
laboratory, which was 1 day for the majority of samples. Even though the total amount 
of bacterial DNA, as well as the diversity of the microbiota may decrease significantly 
in such a time period, the similarities of the fecal samples processed directly and those 
processed after 24 hours remain high36. This applies also for the temperature at which 
the fecal samples are held in the first 24 hours after collection50. 
Finally, in the present study, we made use of parent-reported body weight and height. 
Even though the procedure of measuring weight and height of their child was explained 
and numerous studies have demonstrated that self-reported questionnaires are a valid 
method to estimate body weight and height51, 52, it is known that parents of children with 
a low BMI tend to overreport body weight, while parents of children with a high BMI 
tend to underreport body weight53, 54. Recently we reported a similar underestimation in 
the KOALA study55. This implies that the association we observed between the intestinal 
microbiota and BMI may actually have been stronger than reported. 
Conclusion
Our study indicates that presence of B. fragilis-group in early infancy tended to be 
associated with a higher BMI later in childhood. If causal, this may have important 
public health implications since children with an elevated BMI are more likely to remain 
overweight as adults56. Even a moderate increase in BMI over a long period of time has 
been shown to increase disease risk57. Some studies found that a reduction of 0.25 BMI 
z-scores results in a small improvement in metabolic markers among obese adolescents58 
and a reduction of 0.5 BMI z-scores leads to a major improvement59. Modification 
of the composition of the intestinal microbiota could contribute to the prevention of 
overweight and obesity.
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ABSTRACT
OBJECTIVE: To examine the association between intestinal microbiota composition 
and body weight in children at school age.
METHODS: Within the KOALA Birth Cohort Study faecal samples were collected, 
and height and weight were measured at age 6-7 years. Faecal microbiota composition of 
295 children was determined using the Human Intestinal Tract Chip. Elastic net was used 
to select genus-like bacterial groups (amongst a total of 130) related to anthropometric 
outcomes (age- and sex- standardized weight and BMI z-scores, overweight defined as 
BMI≥85th percentile). Multiple linear and logistic regression were used to associate 
selected bacterial groups with anthropometric outcomes while adjusting for confounders.
RESULTS: Prevotella melaninogenica et rel., Prevotella oralis et rel., Dialister 
and uncultured Clostridiales II (UCII) accounted for 26.1% of the variation in 
microbiota composition. The following bacterial groups were inversely associated 
with anthropometric outcomes: Akkermansia (p=0.030 for BMI; p=0.009 for weight); 
Sutterella wadsworthia et rel. (p=0.008 for BMI; p=0.038 for overweight); Bryantella 
formatexigens et rel. (p=0.050 for weight; p=0.027 for overweight), and Burkholderia 
(p=0.017 for weight). Streptococcus bovis et rel. was positively associated with overweight 
(p=0.013). Among bimodal bacterial groups, high abundance of UCII was inversely 
associated with all three outcomes (adjβ -0.22; 95%CI -0.42 to -0.02 for BMI and 
weight; adjOR 0.28; 95%CI 0.10 to 0.79 for overweight). High abundances of 
Prevotella melanogenica et rel. and Prevotella oralis et rel. were inversely associated with 
overweight (adjOR 0.21; 95%CI 0.07 to 0.68, and adjOR 0.20; 95%CI 0.06 to 0.64, 
respectively). Microbial diversity and richness, and Bacteroidetes:Firmicutes ratio were 
not significantly associated with any of the outcomes.
CONCLUSIONS: In the largest population-based study on childhood gut microbiota 
and body weight so far, we found both new and previously identified bacterial groups 
to be either positively or negatively associated with overweight. Further research should 
elucidate their role in energy metabolism.
INTRODUCTION
The worldwide prevalence of childhood overweight has been growing at an alarming rate 
during the past decades. Overweight children are highly prone to become overweight 
adults and are at high risk of developing comorbidities such as cardiovascular diseases, 
type 2 diabetes, stroke, metabolic syndrome, several types of cancer, and osteoarthritis.1 
As such, the prevention and treatment of childhood overweight remains an important 
public health goal. 
While excessive energy intake and insufficient physical activity are the main drivers of 
childhood overweight and obesity, recent research has suggested that other factors such 
as the gut microbiota may also be involved.2 The gut microbiota is highly diverse in 
composition and plays an important role in human physiology, metabolism, nutrition 
and immune function.3,4 Evidence from human and animal studies [reviewed in5] 
suggests that the gut microbiota may contribute to the development of overweight 
via mechanisms involving increased energy harvest,6 regulation of host metabolism,7 
and the activation of innate immunity.8,9 In humans, obesity has been associated with 
a reduced Bacteroidetes to Firmicutes (B:F) ratio in some studies,10-15 whereas others 
reported the opposite16-18 or no association at all.19-24 Associations between specific 
bacteria (e.g. Bacteroides fragilis,25 Bifidobacterium spp, Staphylococcus spp,26 Akkermansia 
muciniphila27 and Faecalibacterium prausnitzii)20 or archaea (e.g. Methanobrevibacter 
smithii)28 and obesity in humans have also been reported, although the identified 
microbial groups vary greatly between studies. Furthermore, a lower gut microbial 
species and gene richness and diversity in overweight as compared to normal weight 
subjects has been shown in several but not all studies.10,27,29,30
These inconsistent findings might be attributable to the use of miscellaneous methods 
to assess the gut microbiota, often enumerating specific taxa rather than using broad 16S 
rRNA gene surveys or metagenomics. Moreover, studies vary greatly in the populations 
considered, their designs, and the degree of control for potential confounding factors 
such as lifestyle and diet. In human observational studies, carefully controlled data 
analysis is essential.31 Perturbations in microbial diversity and community structure in 
adults with overweight and obesity may be partly due to long-term dietary habits or 
physiological changes in these subjects.30 As such, exploring the association between 
the gut microbiota and variation in BMI and weight in early life, prior to or close 
to the onset of overweight, might provide additional insights. We therefore aimed to 
investigate the relation between gut microbiota composition and body weight in a group 
of 295 well-characterized school-aged children.
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MATERIALS AND METHODS
Subjects and study design
The current study is conducted within the context of the KOALA Birth Cohort 
Study in the Netherlands. The design of the KOALA study has been described 
in detail elsewhere.32 Briefly, a total of 2834 pregnant women were recruited, 
at 34 weeks of gestation, from October 2000 until December 2002. Healthy 
pregnant women with a conventional lifestyle (N=2343) were recruited from 
an on-going cohort study on the aetiology of pregnancy-related pelvic girdle 
pain in the Netherlands.33 To enhance the contrast in lifestyle characteristics, an 
additional 491 pregnant women with alternative lifestyles with regards to dietary 
habits (organic food choice), child rearing practices, vaccination schemes and/or 
use of antibiotics, were recruited through organic food shops, anthroposophist 
doctors and midwives, Steiner schools and dedicated magazines 32
A subgroup of 1,204 parents was asked for consent for a home visit for 
anthropometric measurements and to collect a single faecal sample from the 
child at the age of 6-7 years. This subgroup comprised of participants who had 
home visits for blood collection from the mother during pregnancy and/or the 
child at age 2 years, and who were still active participants (Supplementary Figure 
1). Faecal samples were obtained for n=669 children. Exclusion criteria for the 
current study were: prematurity (infants born before 37 weeks of gestation), twins, 
abnormalities linked to growth (such as Down’s syndrome, Turner syndrome, 
Fallot’s tetralogy, multiple disabilities, and cystic fibrosis), faecal samples with 
transport times exceeding 3 days, or lack of data on dietary intake. A total of 295 
children were finally included in the present study; all being Caucasians. Written 
informed consent was given by all parents, and the study was approved by the 
Medical Ethics Committee of Maastricht University and the National Ethical 
Committee for Medical Research.
Data collection and outcome measures
Faecal collection
Faecal samples of the children were collected by the parents at home upon receipt of a 
faeces tube with a spoon attached to the lid (Sarstedt, Nürmbrecht, Germany) together 
with instructions for collection. A faecal sample was collected and sent to the laboratory 
by mail. After arrival, samples were 10-fold diluted in peptone/water (Oxoid CM0009) 
containing 20% (vol/vol) glycerol (Merck, Darmstadt, Germany), and stored at -80oC 
until further analysis.
Faecal DNA isolation and microbiota profiling
DNA isolation from faecal samples has been described in detail elsewhere.34 Briefly, 
DNA was isolated using a combination of Repeated-Bead-Beating (RBB) and column 
purification. DNA concentration and purity were assessed with a Nanodrop 1000 
spectrophotometer (Thermo Fisher Scientific, Wilmington, USA). DNA was then stored 
at -20oC pending microbial analysis, which was performed using a previously described 
and benchmarked35-37 custom made, phylogenetic microarray, the Human Intestinal 
Tract Chip (HITChip).36 After DNA extraction, the full-length 16S rRNA gene was 
amplified, followed by in vitro transcription and labelling of the resultant RNA with 
Cy3 and Cy5 before hybridization to the array.36 Each sample was hybridized at least 
twice to ensure reproducibility, and raw signal intensities were normalised as previously 
described.38 For the data analysis, hybridization signals were summarized to 130 genus-
like phylogenetic groups (>90% 16S rRNA gene sequence similarity) referred to as species 
and relatives (‘et rel.’).36 The log10-transformed signals were used as a proxy for bacterial 
abundance. B:F ratio was calculated by dividing total hybridisation signal intensities for 
Bacteroidetes by Firmicutes. Diversity of the microbiota was quantified using Shannon’s 
diversity index based on non-logarithmic oligo-level signals as implemented by the R 
package vegan.39 Probes were counted in each sample to measure richness, by using an 
80% quantile threshold for detection.
Anthropometric outcomes 
Height and weight were measured during home visits by trained research assistants at the 
age of 6-7 years, with the children wearing only their underwear. Height (in millimetres) 
was measured using a portable stadiometer (Leicester height measure) and weight (in 
grams rounded off to 100 g) using a digital scale (HE-5, CAS Corp., East Rutherford, NJ, 
USA). BMI was calculated as weight divided by height squared. The BMI, weight and 
height measurements were then converted into age- and gender-specific z-scores using 
the children from the Dutch National Growth Study as the reference population.40 BMI 
z-scores were used both as continuous and dichotomous outcomes: without overweight 
vs. with overweight (BMI z-score ≥1.04, corresponding to the 85th percentile).41
Potential confounders
At 14 and 34 weeks of gestation, pregnant women received questionnaires regarding, 
amongst others, family size, pre-pregnancy height and weight, and weight gain during 
pregnancy. Two weeks after childbirth, data was collected from obstetric reports, and 
questionnaires were completed by the mothers to obtain information on gestational 
age, birth weight and gender of the child. Food frequency questionnaires (FFQs) were 
filled out by the parents to report the dietary habits of their children at the age of 
5.0±0.6 years (mean±standard deviation (SD)). Included confounders are listed in 
Supplementary Table 1.
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Statistical analysis
Characteristics of the study population are presented as mean±SD for continuous 
variables, and proportions for categorical variables. The microbiota profile, summarized 
into 130 genus-like phylogenetic groups was obtained for the 295 subjects. Using 
statistical software package Canoco 5,42 redundancy analysis (RDA), a multivariate 
canonical ordination analysis method, was performed to determine how much variation 
in species composition was explained by the anthropometric outcomes and potential 
confounders.
Selection of potentially relevant bacterial groups
In order to prevent issues with multi-collinearity and multiple testing when performing 
regression analyses with large numbers of determinants, we first selected genus-like 
bacterial levels potentially associated with childhood (over)weight using the elastic 
net regularization proposed by Zou & Hastie.43 Elastic net is a method that utilises 
the ridge (a=0) and lasso (a=1) penalties to perform both shrinkage and automatic 
variable selection simultaneously. It also addresses the problem of multi-collinearity by 
encouraging a grouping effect, where strong correlated genus-like bacterial levels are 
kept in the model. The data was divided at random into two parts: a training set with 
197 observations, and a test set with 98 observations (Figure 1). Model fitting and 
tuning parameters (λ, and s) selection was done on the training set by performing a 
10-fold cross-validation. The first tuning parameter (λ) plays a role in variable selection, 
whereas the second (s) captures correlated predictors at the same time. The chosen grid 
values were: (0, 0.01, 0.1, 1, 10, and 100) for λ, and (0 to 1 dividing on a scale of 0.1) 
for s as previously suggested.43 The most parsimonious model was obtained using the 
combination of the two tuning parameters corresponding to the smallest mean-squared 
prediction error based on the cross-validations performed on the training set. Validation 
of the model performance was then performed by comparing the computed prediction 
mean squared error (for continuous outcomes) on both the training and test set. In 
the case of the binary outcome (overweight (yes/no)) validation of the performance of 
model prediction was done using area under the curve.
In addition, we a priori planned to examine the association between bacterial groups that 
exhibited a strong bimodal abundance distribution (calculated using potential analysis44 
with the early warnings R package45) and anthropometric outcomes. These bimodal 
bacterial groups were previously described Lahti et al. as potential tipping elements 
in the ecosystem,38 and might serve as indicators of the community state and its link 
with (over)weight. We selected bacterial groups that showed consistent evidence for 
multimodality with bootstrap support ≥68%.
Regression analysis
First we performed unadjusted regression models (further referred to as Model 1) 
to analyse the association of each individual selected genus-like bacterial group (as 
identified by elastic net), bimodal bacterial groups (tipping elements), microbial richness 
and diversity, and B:F ratio, with the outcomes (linear regression for BMI and weight 
z-scores, logistic regression for overweight yes/no).
Second, we performed the same analyses while adjusting for potential confounders 
considered a priori (Model 2). We investigated whether the association between the 
intestinal microbiota composition and outcomes differed between the two different 
recruitment channels (alternative and conventional) by including a recruitment group-
exposure interaction term in the models. This interaction was significant only for B:F 
ratio with regards to BMI and weight z-scores (data not shown).
Finally, we performed multiple regression models including all selected bacterial groups, 
the bimodal bacterial groups, and archaea (M. smithii (yes/no) and M. stadtmanae (yes/
no)) while adjusting for the potential confounders (Model 3). Archaea were added 
because in our previous study,28 the presence of archaea, specifically Methanobrevibacter 
smithii, was associated with childhood weight development.
Maternal weight gain during pregnancy was the only confounding variable with ≥5% 
missing values. Multiple imputations were done for this variable to assess whether results 
obtained from the imputed data deviated from the non-imputed. This was done using 
the Markov chain Monte Carlo (MCMC) method for multiple imputations. Results 
obtained from combined imputed datasets (n=10) were comparable with those of the 
original non-imputed data, hence final analyses were done without imputation. Analyses 
were performed in R V.3.1.3 using the following packages: elastic net (for continuous 
outcomes) and glmnet (for binary outcomes), and SAS version 9.3 (SAS Institute, Cary 
NC). Significance level was set at <0.05.
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Burkholderia  
Catenibacterium mitsuokai et rel 
Clostridium leptum et rel 
Dialister* 
Eubacterium hallii et rel 
Eubacterium rectale et rel 
Eubacterium ventriosum et rel 
Prevotella melaninogenica et rel* 
Parabacteroides distasonis et rel 
Ruminococcus callidus et rel 
Streptococcus bovis et rel 
Sutterella wadsworthia et rel 
uncultured Clostridiales I 
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Model 1(Unadjusted): respective outcome = either only: individual bacterial group; bimodal group; richness; diversity; B:F ratio  
Model 2 (Adjusted): respective outcome = either individual bacterial group; bimodal group; richness; diversity; B:F ratio + potential confounder 
Model 3 (adjusted): respective outcome = all selected bacterial groups from the same outcome +  -Confounders 
-Bimodal groups (tipping elements) 
-presence of Archaea (yes/no) 
Figure 1: Schematic overview of the bacterial groups that were selected by elastic net for 
subsequent regression analysis.
*Genus-like bacterial groups identified as having a bimodal abundance distribution were 
analysed as dichotomous variables in the linear and logistic regression models.
RESULTS 
General characteristics of the total KOALA population and of the current study 
population are presented in Table 1. A total of 295 subjects (148 (50.2%) boys and 147 
(49.8%) girls) with a mean age of 7.4 years (SD 0.8) were eligible for the present study 
(Supplementary Figure 1). There were 27 (9.8%) overweight children.
The gut microbiota of the children was dominated by Prevotella melaninogenica et rel., 
Bacteroides vulgatus et rel., Ruminococcus obeum et rel., Faecalibacterium prausnitzii et 
rel., and Bifidobacterium (Figure 2). RDA was performed to explore what percentage 
of variability of gut microbiota composition was explained by the anthropometric 
measures. The percentage of variability explained by each anthropometric measure 
under consideration was very low: 0.5% (p=0.15), 0.6% (p=0.06), and 0.5% (p=0.09) 
by BMI z-scores, weight z-scores, and overweight, respectively (data not shown). We 
observed strong or moderate bootstrap support for a bimodal distribution in the 
abundance of Prevotella melaninogenica et rel., Prevotella oralis et rel., Dialister, and 
uncultured Clostridiales II (UCII), but not for Bacteroides fragilis et rel., and uncultured 
Clostridiales I (UCI). A distribution plot for each of the bacterial groups exhibiting 
bimodality (classified as low or high) and their cut-off or tipping points are illustrated 
in Supplementary Figure 3. 
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Table 1. General characteristics of the KOALA Birth Cohort and the study population
KOALA Birth Cohort 
Study
(N=2834)a
Mean ± SDc
Study Population
(N=295)b
Mean ± SDc
Age at home visit (years) - 7.4 ± 0.8
Anthropometric data measured at home visit
Overweight: n (%)
yes - 27 (9.8)
no - 268 (90.2)
BMI z-scores - -0.16 ± 0.89
Weight z-scores - -0.20 ± 0.96
Time of last antibiotic course prior to home visit: n (%)
No antibiotic use in the previous year - 248 (85.2)
Greater than 4 weeks ago - 36 (12.4)
Less than 4 weeks ago - 7 (2.4)
Age at faecal sample collection (years) - 7.3 ± 0.8
Child’s total physical activity (hrs/week) - 9.4 ± 4.5
Recruitment group
Conventional 2343 (82.7) 218 (73.9)
Alternative 491 (11.3) 77 (26.1)
Maternal educational level (n, %)d
Low 289 (10.7) 21 (7.2)
Middle 1060 (39.4) 113 (38.8)
High 1341 (49.9) 157 (54.0)
Maternal pre-pregnancy weight (Kg) 67.7 ± 13.1 68.3 ± 11.5
Maternal weight gain in pregnancy (Kg) 14.3 ± 5.1 14.5 ± 4.8
Place and mode of delivery: n (%)c
Vaginal delivery at home 1187 (44.8) 143 (49.0)
Vaginal delivery in the hospital 1149 (43.4) 120 (41.1)
Caesarean section in the hospital 311 (11.8) 29 (9.9)
Maternal smoking in late pregnancy: n (%)
Yes 200 (7.1) 12 (4.1)
No 2634 (92.9) 283 (95.9)
Total Household size 4.3 ± 0.8 4.3 ± 0.8
Gestational age 39.8 ± 5.0 39.8 ± 3.7
Birth weight (g) 3503 ± 512 3605 ± 466
Breastfeeding duration (months) 4.7 ± 3.0 6.0 ± 4.4
Gender: n (%)
Male 1451 (51.2) 148 (50.2)
Female 1376 (48.6) 147 (49.8)
Child’s dietary intake
Total energy intake (KJ) 6173 ± 1285 6180 ± 1217
% energy intake from fats 29.6 ± 4.2 29.7 ± 4.2
% energy intake from carbohydrates 55.8 ± 5.0 55.7 ± 4.8
Total fibre intake (g) 15.3 ± 4.0 15.6 ± 3.9
a,bTotal may not sum up to 2834 and 295 respectively due to missings.
cValues are mean (standard deviation), unless indicated otherwise.
dLow: primary school, preparatory vocational or lower general secondary school, Middle: vocational, higher general 
secondary and pre-university, High: higher vocational or academic.
Figure 2: Boxplots representing the relative abundance of the 21 most abundant taxa (mean 
abundance >1%).
The cumulative abundance of the four bimodal groups accounted for 26.1% of 
the variation, with largest variation explained by Dialister, Prevotella oralis et rel. 
and melaninogenica et rel., and their co-correlating species (Figure 3).
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Figure 3. Abundance of bimodal taxa shape overall composition. RDA visualising microbiota 
composition of all faecal samples (n=295) coloured by high (black dots) and low (grey 
dots) abundance of Dialister (left panel), and Prevotella melaninogenica (right panel). 
Overweight individuals are represented as squares. The direction of the arrows depicts the 
abundance of the bimodal bacterial groups as well as their co-correlating groups. Length of 
the arrows is a measure of fit for the species.
Considering the bimodal bacterial groups, a high abundance of UCII was inversely 
associated with BMI- and weight z-score, (adjb -0.22; 95%CI -0.42 to -0.02 for 
both; Table 2) and overweight (adjOR 0.28; 95%CI 0.10 to 0.79; Table 3) in the 
adjusted analysis. Higher abundances of Prevotella melanoginica et rel. (adjOR 
0.21; 95%CI 0.07 to 0.68) and Prevotella oralis et rel. (adjOR 0.20; 95%CI 0.06 
to 0.64) were inversely associated with overweight (Table 3). Regarding microbial 
richness, diversity, and B:F ratio, we only found a borderline significant inverse 
association between microbial diversity and overweight in the unadjusted linear 
regression model. Overall, microbial richness and diversity and B:F ratio appeared 
not be associated with anthropometric outcomes in the childhood population studied.
We subsequently examined whether specific bacterial groups were associated with 
the anthropometric outcomes under study. Elastic net was applied to the 130 genus-
like bacterial groups for each outcome measure separately. A total of 5, 19, and 
9 weight-associated bacterial groups were identified as main effects with regards 
to BMI z-scores, weight z-scores, and overweight, respectively (Figure 1). The 
elastic net coefficient paths for these bacterial groups with respect to each outcome 
are presented in Supplementary Figures 2a-c. The selected bacterial groups were 
included as continuous variables in the regression models, except for Prevotella 
melanogenica et rel. and Dialister spp. (weight z-scores), and UCII (overweight) as 
they were already identified as having a bimodal abundance distribution and as such 
were analysed as dichotomous variables.
After adjusting for confounders (Table 2, Model 2), BMI z-score was inversely associated 
with Akkermansia (p=0.030), and Sutterella wadsworthia et rel (p=0.008). Similar results 
were obtained from Model 3, which included all five pre-selected genus-like bacterial 
groups, other microbial groups (archaea, bimodal bacterial groups), and confounders 
(Supplementary Table 2). Weight z-scores were inversely associated with Akkermansia 
(p=0.009), Burkholderia (p=0.017), and Bryantella formatexigens et rel. (borderline 
significant; p=0.050) after adjusting for confounders (Table 2, Model 2). In the model 
with all 19 pre-selected bacteria adjusted for confounders plus other microbial groups 
(supplementary Table 2, Model 3); only Akkermansia, and Bryantella formatexigens 
remained inversely associated with weight z-scores. With regards to overweight, Sutterella 
wadsworthia et rel. (p=0.038), and Bryantella formatexigens et rel. (p=0.027), were 
inversely associated with overweight in the adjusted analyses. In contrast, Streptococcus 
bovis et rel. (p=0.013) was positively associated with overweight. In the model with all 
nine pre-selected bacteria, other microbial groups, and confounders (Supplementary 
Table 2, Model 3), only Akkermansia remained significantly inversely associated 
with overweight. Overall, Akkermansia, Sutterella wadsworthia et rel., and Bryantella 
formatexigens et rel. were consistently associated with the three anthropometric outcomes, 
even after adjusting for the presence of other gut microbial groups and confounders.
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DISCUSSION
Within a population of 295 school-aged children participating in the KOALA-study, 
we examined the association between microbiota composition and overweight. So far, 
this is the largest population-based study on childhood gut microbiota in relation to 
body weight. Moreover, the extensive data on lifestyle and diet allowed us to carefully 
control for potential confounding factors. The anthropometric outcomes and potential 
confounders explained very little variation in the overall microbiota composition; 
however, the abundances of several specific bacterial groups were consistently linked to 
BMI-, weight z-scores, and overweight.
The gut microbiota of 6-7 year-old children is less well studied than that of adults, and 
it is still being debated whether the composition has reached a relatively stable, adult-
like state soon after weaning46 or continues developing into teen years.47 An in-depth 
comparison with adults is beyond the scope of this paper, however, it is noteworthy that 
we observed several bimodal distributed bacterial groups as well as their co-correlating 
species that were previously reported to be present in healthy adults,38 including UCII, 
Prevotella spp. (P. oralis et rel. and P. melaninogenica et rel.) co-correlating with P. 
ruminicola et rel., and Dialister with uncultured Selenomodaceae. Lack of support for 
bimodality of UCI in our study is also in concordance with Lahti et al,38 who showed 
previously that UCI exhibits very clear shifting state probabilities associated with 
ageing, where the high abundant state was only observed above 40 years of age. Since the 
bootstrap support of bimodality for Bacteroides fragilis was only moderate in the study 
of Lahti et al., this bimodality might have been missed in our study due to the smaller 
sample size, age, health status, or other biological factors.
The abundance of the four bimodal groups explained 26.1% of the variation in species 
composition, compared to <1% for each of the anthropometric outcomes. Therefore, we 
cannot confirm the often large-scale community shifts previously reported mainly from 
rodent studies.6,29 In this group of healthy children within a relatively normal weight 
range, weight and associated parameters therefore did not seem to be major drivers 
of overall microbial composition or vice versa. This is in line with observations from 
Hollister et al., who also found that BMI failed to account for a significant proportion 
of the variation in gut microbial composition and function of American children at 
age 7-12 years.47 The B:F ratio was not associated with weight-related outcomes in the 
present study. Although previous studies have reported a lower B:F ratio in individuals 
with overweight or obesity as compared to normal weight individuals,10-15 others studies 
found the opposite association,16-18 or analogous to our study, no association at all. 19-24 
A healthy gut microbial ecosystem is generally thought to be characterised by high 
microbial richness and diversity, presumed to indicate a more stable and resilient state 
of this ecosystem.48 A lower richness/diversity of the gut bacterial communities has 
been reported in subjects with obesity, and overweight compared to normal weight 
individuals.13,30,49 We also observed a tendency towards a lower gut microbial diversity in 
overweight compared to normal weight children. However, this association disappeared 
upon adjusting for confounders. This implies that differences in microbial diversity 
between obese and lean subjects, as observed in previous studies not comprehensively 
controlling for confounders may be overestimated. Altogether, our results confirm that 
the B:F ratio and diversity appear not to be a general feature distinguishing the normal 
and overweight human gut microbiota across populations.50
Although we did not find a significant association with the overall microbial community 
composition, we did observe associations between the anthropometric outcomes and 
the contrasting alternative stable states of specific bacterial groups that could potentially 
act as tipping elements of the whole gut microbial ecosystem. We could confirm the 
observation by Lahti et al. (2014) that UCII was inversely associated with BMI. We 
found an inverse association with BMI- and weight z-scores, and with overweight. 
Likewise, higher abundances of P. oralis et rel. and P. melaninogenica et rel., were 
inversely associated overweight even after adjusting for other microbial groups that were 
also associated with overweight, but not with the other outcomes. In addition, using 
the elastic net statistical method of variable selection,43 we identified several bacterial 
groups, of which Akkermansia, Bryantella formatexigens et rel. and Sutterella wadsworthia 
et rel. were consistently associated with all three anthropometric outcomes. The inverse 
association between Akkermansia abundance and body weight is consistent with previous 
studies both in mice and humans.27,51-53 Although the precise mechanism through which 
Akkermansia influences host metabolism has not yet been fully elucidated, studies in 
mice have demonstrated that it is involved in the reduction of metabolic endotoxemia, 
which is characteristic of obesity and associated metabolic disorders, through the 
restoration of gut barrier function.54 Bryantella formatexigens et rel. has been shown 
to ferment glucose to acetate in the presence of high formate concentrations55 and the 
production of acetate can result in appetite suppression,56 suggesting a mechanism by 
which these bacteria might be linked to lower weight. Sutterella wadsworthia et rel. has 
been suggested to a play a role in autism spectrum disorder in children,57 but its role in 
overweight development has not been reported before. 
The strengths of this study compared to previous cross-sectional studies on the gut 
microbiota and childhood overweight are; its large sample size in combination with a 
broad and high resolution interrogation of the whole gut microbial community, and 
extensive adjustment for important confounding variables (especially diet and physical 
activity). This allowed us to select bacterial groups (out of a total of 130) that were 
associated with weight-related outcomes, without an a priori constraint on the target 
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species. In addition, our study is one of the first to examine the association between 
microbiota composition and body weight in a population of mostly lean, healthy 
children. Previous studies focused on extreme categories of lean and obese individuals. 
As a consequence, differences in microbiota composition might be less prominent in our 
study as compared to these previous studies, but it provides insight in the role of the gut 
microbiota in the normal developing child.
A limitation of the present study was the transport time for faecal samples, which ranged 
from less than 1 to 3 days at ambient to room temperature. This might have affected 
the measurable diversity and structure of the bacterial communities. However, several 
previous studies have shown that the microbial diversity and composition of faecal 
samples is much more affected by inter-individual differences and biases in molecular 
techniques rather than differences in short-term storage conditions, including storage 
for up to 2 weeks at room temperature.58,59 Furthermore, we could only assess the 
associations of the bacterial groups with weight outcomes at one time point, and as 
a result causality could not be established. However, only a few longitudinal studies 
have been published so far in this field.25,60 Hence, large longitudinal cohort studies 
that characterise the gut microbiota at multiple time points and collect detailed data 
on important confounding variables (e.g. mode of delivery, diet, and physical activity) 
are needed to obtain an in-depth knowledge of the relation between gut microbiota 
dynamics and childhood weight development. The ongoing follow-up of the children 
in our study facilitates a future longitudinal investigation of our findings taking into 
account these important confounding factors.
In conclusion, weight-related outcomes failed to explain much of the observed variation 
in gut microbiota composition in our cohort of healthy children, suggesting that at least 
in this group of individuals, weight-related parameters (BMI and weight z-scores, and 
overweight) are not major drivers of microbial composition in the gut. Nonetheless, 
several specific bacterial taxa appeared to be consistently associated with weight-related 
outcomes. These include several bacteria that have previously been linked to weight-
related outcomes (Akkermansia, UCII), as well as species that have not previously been 
linked to (over)weight such as Sutterella wadsworthia et rel. and Bryantella formatexigens 
et rel. In this regard, more detailed information on their functional role in energy 
metabolism will help to establish their importance for weight development. Our results 
provide new avenues with regards to bacteria in the gut of humans in relation to the 
increasing trend of overweight worldwide.
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SUPPLEMENTAL MATERIAL
Supplementary Table 1. List of potential confounding variables
Potential confounders Variable description/labela
Recruitment group Categorical
• 0 - alternative
• 1 - conventional
Maternal educational level Categorical
• 0 - lower education
• 1 - vocational education
• 2 - higher general secondary/pre-university
• 3 - higher vocational/academic education
Maternal pre-pregnancy weight Continuous
Weight gained during pregnancy Continuous
Maternal smoking status Categorical
• 0 - no 
• 1- yes
Place and mode of delivery Categorical
• 0 - vaginal delivery at home
• 1 - vaginal delivery in hospital
• 2 - caesarean section in hospital
Gestational age Continuous 
Gender Categorical
• 0 - male 
• 1- female
Birth weight Continuous
Household size Continuous
Duration of breastfeeding Continuous
Child’s dietary intake
Total energy intake (KJ) Continuous
% energy intake from fats Continuous
% energy intake from carbohydrates Continuous
Time of last antibiotic course prior to home visit Categorical
• 0 - no antibiotic use in the previous year 
• 1- greater than 4 weeks ago 
• 2 - less than 4 weeks ago
Physical activity Continuous
Age at faecal sample collection (years) Continuous
aAll zero values were treated as reference category for each categorical variable.
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Supplementary Figure 1. Flow chart illustrating how the present study population of 295 children 
was obtained from the initial KOALA cohort of 2834 healthy pregnant women.
Parents approached for child’s 
faecal sample 
n=1204 
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analysis 
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Supplementary Figure 1. Flow chart illustrating how the present study population of 295 
children was obtained from the initial KOALA cohort of 2834 healthy pregnant women.
Supplementary Figure 2. Coefficient paths for the elastic net regression models applied 
to the gut microbiota data. (a) Elastic net regression estimates for BMI z-scores with the 
optimal lambda value (λ=0.1) as obtained from ten-fold cross-validation parameters and 
s=0.1 on the horizontal axis. Selected bacterial groups with non-zero coefficients are the 
lines that fall below the cut-off value s=0.1 (n=5); (b) elastic net regression coefficients for 
weight z-scores with tuning parameters (λ =0.01 and s=0.2) and non-zero bacterial group 
coefficients below s=0. (n=19); (c) elastic net regression coefficients for overweight with 
tuning parameters (λ =0.01 and s=0.1) with non-zero coefficients below s=0.1 (n=9). 
a
b
c
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Supplementary Figure 3. Logarithmic abundance distributions of the four bacterial groups that exhibited a bimodal abundance across the gut microbiota of 295 children. 
High and low abundance states are separated by a dashed red line. Proportion of children with high levels of bimodal bacterial groups; 47.1%, 47.8%, 44.1% and 57.3% for 
Prevotella melanogenica et rel., Prevotella oralis et rel., Dialister and UCII respectively. UC II refers to the Uncultured Clostridiales II. 
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Supplementary Figure 3. Logarithmic abundance distributions of the four bacterial 
groups that exhibited a bimodal abundance across the gut microbi ta of 295 children. 
High and low abundance states are separated by a dashed red line. Proportion of children 
with high levels of bimodal bacterial groups; 47.1%, 47.8%, 44.1% and 57.3% for Prevotella 
melanogenica et rel., Prevotella oralis et rel., Dialister and UCII respectively. UC II refers to 
the Uncultured Clostridiales II.
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Abstract
Objective: To prospectively investigate the presence and counts of archaea in faeces of 
472 children in association with weight development from 6-10 years of age.
Methods: Within the KOALA Birth Cohort Study, a single faecal sample from each child 
was analysed by qPCR to quantify archaea (Methanobrevibacter smithii, Methanosphera 
stadtmanae). Anthropometric outcomes (overweight (BMI≥85th percentile), age- and 
sex-standardized BMI, weight, and height z-scores) were repeatedly measured at ages 
(mean±SD) of 6.2±0.5, 6.8±0.5, 7.8±0.5, and 8.8±0.5 years. Generalized Estimating 
Equations was used for statistical analysis while controlling for confounders.
Results: M. smithii colonization was associated with an increased risk of overweight 
(adjusted odds ratio (OR)=2.69; 95%CI 0.96-7.54) from 6-10 years of age. Children 
with high levels (>7log
10
copies/g faeces) of this archaeon were at highest risk for 
overweight (OR=3.27; 95%CI 1.09-9.83). Moreover, M. smithii colonization was 
associated with higher weight z-scores (adjβ 0.18; 95%CI 0.00-0.36), but not with 
height. For BMI z-scores, the interaction (P=0.008) between M. smithii and age, was 
statistically significant, implying children colonized with M. smithii had increasing BMI 
z-scores with age.
Conclusion: Presence and higher counts of M. smithii in the gut of children is associated 
with higher weight z-scores, higher BMI z-scores and overweight.
Introduction
{Salonen, 2010 #98}Over the past decades childhood overweight and obesity have 
reached epidemic proportions in most industrialized countries.1 Since 1980, there has 
been a two to three fold increase in childhood overweight and four to six fold increase 
in obesity in the Netherlands.2 Eventually, children with overweight or obesity are more 
likely to become obese adults,3, 4 leading to increased risk for chronic diseases, including 
cardiovascular disease, hypertension, type 2 diabetes mellitus and premature mortality.2 
Moreover, once obesity is established, it is difficult to reverse through interventions.5
Recently, a role of the gut microbiota has been put forward. The human gut microbiota 
is a complex, densely populated ecosystem, mainly consisting of bacteria.6 Besides the 
many bacterial species, the human gut contains several archaeal species, which are 
considered to play a crucial role in the metabolic capacity of the human gut microbiota. 
To date, only three distinct species within the group of methanogenic archaea have been 
isolated from human faeces, Methanobrevibacter smithii,7Methanospaera stadtmanae8 and 
Methanomassilicoccus luminyesis.9 In children from 1 to 10 years of age, the prevalence 
of these methanogenic species have been found in, 88%, 11% and 1% of the children 
respectively.10
Methanogens use hydrogen, a by-product of bacterial fermentation, to produce methane. 
The removal of hydrogen accelerates the bacterial fermentation of polysaccharides and 
carbohydrates, leading to the more efficient production of short-chain fatty acids which 
can serve as an additional energy source for the host.11-15
Several studies, both in animal models and humans have suggested a potential role 
for archaea, specifically M. smithii, in the development of overweight/obesity. Using a 
mouse model, Samuel and colleagues, illustrated that colonization with M. smithii leads 
to increased utilization of dietary fibre and increased adiposity.16  Another study revealed 
a significant increase in M. smithii in mice fed with high-fat chow compared to those fed 
with normal chow.17 Only few studies have addressed the relationship between archaea 
and host energy balance in humans. In a small study including 9 human participants, 
Zhang et al.18 detected significantly higher numbers of H
2
-utilizing methanogenic 
archaea in obese individuals compared to normal-weight as well as post-gastric-bypass 
individuals. In contrast, other studies have reported lower amounts of M. smithii in 
obese compared to lean individuals.19, 20 These results demonstrate that more research 
is needed to unde{Altschul, 1997 #87}rstand the role of archaea in obesity.20  Most of 
the studies reporting a positive association between methanogenic archaea and obesity 
were based on breath methane measurements. A study among 58 obese subjects showed 
a significantly higher BMI among breath methane-positive as compared to methane-
negative subjects.21 Moreover, in a large study among 792 subjects the presence of 
both hydrogen and methane on breath testing was associated with a higher BMI and 
percent body fat. 22 Breath methane measurements alone may however underestimate 
the number of participants with methanogenic archaea due to the lower sensitivity 
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(62%) as compared to molecular detection of methanogens in stools. 23, 24 Moreover, 
the main evidence originates from animal studies and the limited number of human 
studies that used faecal samples had small sample sizes hence low power to detect a 
significant association, and a cross-sectional design. Lastly, none of these studies has 
been performed in children.
Therefore, we aimed to investigate whether the presence and counts of archaea in 
the faecal samples of 472 children at school age is associated with childhood weight 
development from 6 to 10 years of age.
Methods
Study design
The present study was conducted within the prospective KOALA Birth Cohort Study, 
in the Netherlands. The design of this study has been described in detail elsewhere.25 A 
total of 2834 pregnant women were recruited, at 34 weeks of gestation, from October 
2000 until December 2002. Healthy pregnant women with a conventional lifestyle (n 
2343) were retrieved from an on-going cohort study on the aetiology of pregnancy-
related pelvic girdle pain in the Netherlands. An additional 491 pregnant women 
with alternative lifestyles were recruited through organic food shops, anthroposophist 
doctors and midwives, Steiner schools and dedicated magazines. This latter group of 
women was considered to have an alternative lifestyle that could involve dietary habits 
(vegetarian, organic food choice), child rearing practices, vaccination schemes and/or 
use of antibiotics. Exclusion criteria for the present study were: prematurity (< 37 weeks 
of gestation), twins, abnormalities linked to growth (such as Down’s syndrome, Turner 
syndrome, Fallot’s tetralogy, multiple disabilities, and cystic fibrosis), and faecal samples 
whose transport time was greater than 4 days. All children included in this study were 
Caucasians. Informed consent was given by all parents, and the study was approved 
by the Medical Ethics Committee of Maastricht University and the National Ethical 
Committee for Medical Research.
Data collection and longitudinal outcome measures
At 14 and 34 weeks of gestation, pregnant women received questionnaires collecting 
data on amongst others family size, pre-pregnancy height and weight, and weight gain 
during pregnancy. Two weeks after childbirth, data was collected from obstetric reports 
and questionnaires were completed by the mothers to obtain data on gestational age, 
birth weight and gender of the child. Food frequency questionnaires were filled out 
by the parents to report the dietary habits of their children at the age (mean±standard 
deviation (SD)) of 5.0±0.6 years.
Parent-reported weight and height of children was repeatedly assessed by mailing follow-
up questionnaires to the parents in 2007, 2008, 2009 and 2010. This corresponds to 
longitudinal assessment of the children’s’ height and weight at the ages (mean±SD) of 
6.2±0.5, 6.8±0.5, 7.8±0.5, and 8.8±0.5 years respectively.
BMI was computed as weight divided by height squared (kg/m2). The BMI, weight and 
height measurements were then converted into age- and gender-specific z-scores using 
the Dutch National growth study26 as the reference population. BMI z-scores were used 
both as continuous and dichotomous outcomes. Dichotomisation into normal weight 
vs. overweight was based upon a cut-off of a z-score ³ 1.04, equivalent to BMI z-scores 
³ 85th percentile standardized for age and gender.27
Faecal sample collection
A subgroup of this cohort (n=1204), i.e. the participants who were visited at home for 
blood collection from the mother during pregnancy and/or the child at age 2 years, and 
were still active participants at child’s age of 6-7 years (Figure 1), was asked to collect 
a single faecal sample from their children at school age. Faeces collection tubes with 
spoon attached to their lids (Sarstedt, Nümbrecht, Germany) together with collection 
instructions were sent to the parents of participating children. A faecal sample was 
collected and sent to the laboratory by mail. Upon arrival in the laboratory, faecal 
samples were 10-fold diluted in peptone/water (Oxoid CM0009) containing 20% (vol/
vol) glycerol (Merck, Darmstadt, Germany) and stored at -80oC until further analysis.
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Figure 1. Flow chart illustrating how the present study population of 472 children was 
obtained from the initial KOALA cohort of 2834 healthy pregnant women.
Faecal DNA isolation and Real-time quantitative PCR
DNA isolation from faecal samples has been described in detail elsewhere.28 In brief, 
the DNA was isolated using a combination of Repeated-Bead-Beading (RBB) plus 
column purification method. Concentration and purity of the DNA were assessed with 
a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, USA). 
DNA from all faecal samples was subjected to 5’-nuclease based real-time PCR assays 
for the enumeration of M. smithii and M. stadtmanae (primers and probes are listed 
in Table 1). For both M. smithii and M. stadtmanae, amplifications were conducted 
in a total volume of 25 μL, containing 1× Absolute qPCR Mix (ABgene, Hamburg, 
Germany), 200 nM of forward and reverse primers, 200 nM TaqMan probe, and 2 μL 
of tenfold diluted target DNA. The amplification (2 minutes at 50°C, 10 minutes at 
95°C, and 42 cycles of 15 seconds at 95°C and 1 minute at 60°C) and detection were 
conducted with an Applied Biosystems Prism 7900 sequence detection system (Applied 
Biosystems). 
Table 1. Real-time PCR primers and probe sequences for detecting M. smithii and M. 
stadtmanae 16S rRNAa
Target organisms  
(amplicon size)
Primer/probe Sequence (5’- 3’) T
m
(oC)
M. smithii (123 bp) Forward primer 5’-CCGGGTATCTAATCCGGTTC-3’ 63.0
Reverse primer 5’-CTCCCAGGGTAGAGGTGAAA-3’ 64.0
Probe 5’-CCGTCAGAATCGTTCCAGTCAG-3’ 61.0
M. stadtmanae (97 bp) Forward primer 5’-AGGAGCGACAGCAGAATGAT-3’ 64.0
Reverse primer 5’-CAGGACGCTTCACAGTACGA-3’ 65.0
Probe 5’-TGAGAGGAGGTGCATGGCCG-3’ 71.0
a Reference for information in table; Dridi et al., (2009)8
Quantification of M. smithii and M. stadtmanae was achieved by using a quantification 
plasmid containing the target sequences. Plasmid constructs containing the sequence 
of interest were created as positive controls (see supplemental material S1 and Figure 
S1(a) and (b) for standard curves). The lower limits of detection were 3.81 and 4.82 
log10 copies/g faeces for M. smithii and M. stadtmanae respectively. In the present 
study faecal samples were sent by mail and transport time varied from 0 to 4 days. 
However, the proportion of positive samples as well as the concentration of archaea did 
not significantly differ between samples according to transport time (Chi-square test, 
p-value>0.05).
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Statistical analyses
Characteristics of the children are presented as mean±SD or median (range) for 
continuous variables, and proportions for categorical variables. We used Generalized 
Estimating Equations (GEE) with autoregressive correlation structure to analyse the 
association between archaea and childhood BMI, weight, and height (as z-scores for 
continuous outcomes) and overweight status over time (as binary outcome) including all 
available parent-reported repeated measurements up to 10 years of age. For each of these 
outcomes we examined the effects of colonisation with either M. smithii or M. stadtmanae 
(yes/no) and the counts of each of these species. For M. smithii, we constructed a variable 
accounting for the tri-modal distribution of the counts (uncolonised, low levels (3.5 to 
7 log10 copies/g faeces), high levels (>7 log10 copies/g faeces)) observed (Figure 2). 
To evaluate whether increasing levels of the counts of M. smithii were associated with 
higher BMI z-scores, Cochran Armitage trend test was performed for this exposure–
outcome combination.
Figure 2. Histogram showing the tri-modal distribution of counts (Log10 DNA copies/
gfaeces) for M. smithii.
To investigate whether results differed across ages, we tested for statistical interaction 
between the main independent variables and age of the child at the time of outcome 
measurement as a continuous variable. The interaction term was statistically significant 
only for M. smithii prevalence (yes/no) with BMI z-scores as the outcome (interaction 
p=0.008); hence an age-stratified analysis was performed for this association.
Potential confounders considered for inclusion in the model were: recruitment group 
(conventional or alternative), maternal pre-pregnancy weight, maternal pre-pregnancy 
height, maternal educational level (lower education, vocational education, higher 
general secondary/pre-university, or higher vocational/academic education), weight 
gained during pregnancy, place and mode of delivery (vaginal delivery at home, vaginal 
delivery in hospital, or caesarean section in hospital), gestational age, birth weight, 
household size, antibiotic use (no antibiotics in past year, antibiotic use >4 weeks ago, 
or antibiotic use ≤4 weeks ago), physical activity, gender, and child’s dietary intake 
(total fibre, total energy, fats and carbohydrates both as percentage of total energy). 
Variables that changed parameter estimates of the main independent variable by more 
than 10% were included in the final models. All children (N=472) were included in 
the unadjusted analyses and a total of 406 (86%) children was included in the adjusted 
analyses. The latter was due to missing values in some confounders, ranging from 1.3% 
missing values for mode of delivery and antibiotic use to 6.1% for physical activity. We 
checked whether results obtained following multiple imputations deviated from the 
results obtained without imputation. Multiple imputations were done using all four 
repeated measurements for BMI z-scores, weight z-scores and height z-scores variables 
including confounders with missing values. As results from combined imputed datasets 
(n=10) were comparable with those of the original non-imputed data, we performed the 
final analyses without imputation.
The following statistical software was used: SAS version 9.3 and SPSS version 21.0 
(SPSS Inc., Chicago, IL, USA). A pre-selected significance level of 0.05 was used.
Results
A total of 472 faecal samples were eligible for analysis (Figure 1). M. smithii was present 
in 369 (78.2%), and M. stadtmanae in 39 (8.3%) of the 472 children (Table 2). From all 
these children, at least one anthropometric measurement was available. At time-point 1 
(start of follow-up) anthropometric data were available for 407 out of the 472 children, 
and 6.9% (28/407) of the children were overweight (Table 3). At this same time point, 
the percentage overweight among children colonized with M. smithii was 7.6% compared 
to 4.4% for children not colonized with M. smithii. While the percentage overweight 
among children colonized with M. stadtmanae, was 6.2% compared to 6.9% among 
children not colonized with this archaeon. For the subsequent follow-up time-points 
anthropometric data were available for respectively 376, 348 and 385 out of 472 children.
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Table 3. Anthropometric measures of the study population at the four different follow-up 
time points
 Time-point 1 
(2007)
Time-point 2 
(2008)
Time-point 3 
(2009)
Time-point 4 
(2010)
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Children with anthropometric 
data (n, %)
407 (86.2) 376 (79.7) 348 (73.7) 385 (81.6)
Age (years) 6.2 ± 0.5 6.8 ± 0.5 7.8± 0.5 8.8 ± 0.5
Overweight (n, %)
yes 28 (6.9) 22 (5.9) 31 (8.9)  41 (10.7)
no 379 (93.1) 354 (94.1) 317 (91.1) 344 (89.3)
BMI z-scores -0.33 ± 0.95 -0.37 ± 0.90 -0.26 ± 0.97 -0.22 ± 0.96
Weight z-scores -0.37 ± 0.95 -0.35 ± 0.96 -0.27 ± 0.98 -0.19 ± 0.91
Height z-scores -0.05 ± 0.96 -0.10 ± 0.98 -0.09 ± 0.96 0.08 ± 0.90
Unadjusted and adjusted associations between the presence, counts and levels of counts 
of M. smithii and M. stadtmanae and the different outcome variables are presented in 
Table 4 (for overweight as binary outcome) and Table 5 (for BMI, weight and height 
z-scores as continuous outcomes). In the unadjusted analyses we found no statistically 
significant association between the presence/counts of archaea and overweight status. 
Upon adjusting for confounders, children that were colonized with M. smithii were 
at increased risk of being overweight (adjusted odds ratio (OR) = 2.69; 95%CI 0.96-
7.54). Children with a low level of counts (3.5 to 7 log10 copies/g faeces) of M. smithii 
were twice more likely to be overweight compared to children without this archaeon, 
although this association was not significant (OR
 adjusted 
= 2.40; 95%CI 0.83-6.95). 
Children having a high level of counts (>7 log10 copies/g faeces) of M. smithii were three 
times more likely to be overweight (OR
adjusted 
= 3.27; 95%CI 1.09-9.83). P for trend 
across these levels (none, low and high) of M. smithii and overweight status approached 
significance (Cochran Armitage p=0.066). Analyses on the counts of M. smithii as a 
continuous variable also showed that, a log10 increase in the counts of M. smithii was 
associated with a 10% increased risk of overweight (OR
adjusted 
= 1.10; 95%CI 1.00-1.21). 
No statistically significant association between M. stadtmanae, neither for presence nor 
counts, and overweight status was found.
Regarding BMI z-score as a continuous outcome variable, we found a statistically 
significant interaction between the presence of M. smithii and age (p-value=0.008), 
implying, colonisation with M. smithii was associated with an increasing BMI z-score 
as age increased (Figure 3). However, differences at individual time (age) points after 
stratifying for age did not reach statistical significance (data not shown).
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Figure 3. An interaction plot for the association of M. smithii prevalence and BMI z-scores 
across ages. The horizontal axis is the grouped ages at which different outcomes were 
measured. These are indexed in the variable time as follows (ages (mean±SD) 6.2±0.5, 
6.8±0.5, 7.8±0.5, and 8.8±0.5 years as time 1, time 2, time 3 and time 4 respectively); the 
vertical axis are the predicted BMI z-scores for each child at different time points obtained 
from the final GEE model; different line types represent curves for the two M. smithii 
prevalence groups (smooth line for uncolonised and dotted line for colonized). The smooth 
curves were obtained using spline interpolation. 
Unadjusted analyses for the associations between the presence and counts of M. smithii 
and M. stadtmanae with weight z-scores as a continuous variable were not statistically 
significant. In the adjusted analyses, the presence of M. smithii in children was 
statistically significantly associated with higher weight z-scores (adjβ 0.18; 95%CI 0.00-
0.36) compared to children without this archaeon. In addition, low and high levels of 
M. smithii in children were also associated with higher weight z-scores compared to 
uncolonised children, although this only approached statistical significance (low: adjβ 
0.18; 95% CI -0.01 to 0.36 and high: adjβ 0.20; 95% CI -0.01 to 0.40; Table 5). The 
P for trend across these levels (none, low and high) of counts of M. smithii approached 
significance in association with increasing weight z-scores (p for trend=0.09).
There was no statistically significant association of M. smithii with height z-scores.
For M. stadtmanae, there were no statistically significant associations with any of the 
four outcomes (Table 4 & 5) neither for presence or the counts of M. stadtmanae.
Table 4. GEE results showing association of overweight (yes/no) from 6 to 10 years of age 
with the prevalence of colonisation and counts (Log10DNAcopies/g faeces) of archaea 
species in the gut microbiota at 6-7 yrs of age a
 n Crude OR [95% CI]b Adjusted OR [95% CI]c P-valued
Overweight (No/Yes) 
M. smithii prevalence
No 103 1.00 [reference] 1.00 [reference]
Yes 369 1.75 [0.77 to 3.96] 2.69 [0.96 to 7.54] 0.059
M. smithii count levels
None 103 1.00 [reference] 1.00 [reference]
Low (<7 Log
10
DNAcopies/g faeces) 251 1.64 [0.69 to 3.86] 2.40 [0.83 to 6.95] 0.108
High (>7 Log
10
DNAcopies/g faeces) 118 1.97 [0.80 to 4.85] 3.27 [1.09 to 9.83] 0.035
M. stadtmanae prevalence
No 433 1.00 [reference] 1.00 [reference]
Yes 39 1.20 [0.46 to 3.13] 1.14 [0.53 to 3.90] 0.483
Counts of archaeal species (Log10D-
NAcopies/g faeces)e, median (range)
M. smithii 1.05 [0.97 to 1.34] 1.10 [1.00 to 1.21] 0.047
M. stadtmanae  1.06 [0.92 to 1.22] 1.08 [0.94 to 1.25] 0.265
a GEE = Generalised Estimating Equations
b Sample size used for crude analysis N=472; OR=
c Sample size for adjusted analysis N=428 and N=406 for M. smithii and M. stadtmanae respectively due to missing 
values. Confounders in the final adjusted model for M. smithii: household size, place and mode of delivery, birth weight, 
dietary intake (total fibre intake, total percentage energy intake, percentage energy intake for fats and carbohydrates), 
antibiotic use and physical activity; and for M. stadtmanae: household size, place and mode of delivery, birth weight, 
nutritional intake (total fibre intake, total percentage energy intake, percentage energy intake for fats and carbohydrates), 
physical activity, maternal level of education (low, middle and high), and weight gain during pregnancy
dColumn represents p-values for the adjusted analysis
e GEE analysis was done using archaea (M. smithii and/or M. Stadtmanae) positive samples only.
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Table 5: GEE results showing association of different continuous outcomes (BMI, weight and 
height z-scores) from 6 to 10 years of age with the prevalence of colonisation and counts 
(Log10DNAcopies/g faeces) of archaea species in the gut microbiota at 6-7 yrs of agea
 n Crude β [95% CI]b Adjusted β [95% CI]c P-valued
BMI z-scorese
M. smithii count levels
None 103 0 [reference] 0 [reference]
Low (<7 Log10DNAcopies/g faeces) 251 0.07 [-0.12 to 0.27] 0.10 [-0.09 to 0.29] 0.286
High (>7 Log10DNAcopies/g faeces) 118 0.09 [-0.14 to 0.32] 0.14 [-0.07 to 0.38] 0.194
M. stadtmanae prevalence
No 433 0 [reference] 0 [reference]
Yes 39 0.04 [-0.26 to 0.34] 0.15 [-0.17 to 0.46] 0.358
Counts of Archaeal species (Log
10
DNAcopies/g faeces), median (range)f
M. smithii 0.00 [-0.02 to 0.03] 0.01 [-0.01 to 0.03] 0.436
M. stadtmanae 0.02 [-0.02 to 0.06] 0.03 [-0.01 to 0.07] 0.186
Weight z-score 
M. smithii prevalence
No 103 0 [reference] 0 [reference]
Yes 369 0.13 [-0.06 to 0.31] 0.18 [0.00 to 0.36] 0.046
M. smithii count levels
None 103 0 [reference] 0 [reference]
Low (<7 Log10DNAcopies/g faeces) 251 0.12 [-0.08 to 0.32] 0.18 [-0.01 to 0.36] 0.071
High (>7 Log10DNAcopies/g faeces) 118 0.15 [-0.08 to 0.38] 0.20 [-0.02 to 0.40] 0.077
M. stadtmanae prevalence  
No 433 0 [reference] 0 [reference]
Yes 39 0.16 [-0.15 to 0.48] 0.15 [-0.16 to 0.46] 0.335
Counts of archaeal species (Log
10
DNAcopies/g faeces), median (range)
M. smithii 0.01 [-0.01 to 0.04] 0.01 [-0.01 to 0.04] 0.228
M. stadtmanae 0.04 [-0.01 to 0.08] 0.03 [-0.01 to 0.08] 0.107
Height z-scores 
M. smithii prevalence
No 103 0 [reference] 0 [reference]
Yes 369 0.09 [-0.09 to 0.27] 0.13 [-0.05 to 0.31] 0.170
M. smithii count levels
None 103 0 [reference] 0 [reference]
Low (<7 Log10DNAcopies/g faeces) 251 0.10 [-0.10 to 0.29] 0.14 [-0.05 to 0.34] 0.134
High (>7 Log10DNAcopies/g faeces) 118 0.07 [-0.16 to 0.29] 0.07 [-0.13 to 0.29] 0.477
M. stadtmanae Prevalence  
No 433 0 [reference] 0 [reference]
Yes 39 0.15 [-0.16 to 0.46] 0.06 [-0.27 to 0.39] 0.726
Counts of Archaeal species (Log
10
DNAcopies/g faeces), median (range)
M. smithii 0.01 [-0.02 to 0.03] 0.01 [-0.02 to 0.03] 0.708
M. stadtmanae  0.03 [-0.01 to 0.08] 0.02 [-0.02 to 0.07] 0.369
aGEE = Generalised Estimating Equations
bSample size used for crude analysis N=472
c Sample size for adjusted analysis N=428 and N=406 for M. smithii and M. stadtmanae respectively due to missing 
values. Confounders in the final adjusted model for M. smithii: household size, place and mode of delivery, birth weight, 
dietary intake (total fibre intake, total percentage energy intake, percentage energy intake for fats and carbohydrates), 
antibiotic use and physical activity; and for M. stadtmanae: household size, place and mode of delivery, birth weight, 
physical activity, maternal level of education (low, middle and high), and weight gain during pregnancy 
dColumn represents p-values for the adjusted analysis
eModel with M. smithii prevalence as main determinant in association with BMI z-score not presented due to significant 
interaction with age.
f GEE analysis was done using archaea (M. smithii and/or M. Stadtmanae) positive samples only.
Discussion
This prospective cohort study is the first to demonstrate that the presence as well as the 
counts of methanogenic archaea, specifically M. smithii, in the gut of children at school 
age is associated with more overweight and higher weight z-scores. We also found that 
the strength of the association between colonization with M. smithii and BMI z-scores 
increased with age from 6 to 10 years. 
Several previous studies16,18 supported the hypothesis that archaea (M. smithii) 
contribute to energy harvesting and hence weight development. Samuel and Gordon, 
2006,16 observed that M. smithii played a critical role in facilitating an increased capacity 
of B. thetaiotaomicron to digest polyfructose-containing glycans leading to increased 
production of short-chain fatty acids (SCFAs) and total liver triglycerides in mice. Mice 
colonized with B. thetaiotaomicron and Desulfovibrio piger instead of M. smithii, did not 
show such an effect, highlighting the key role of M. smithii in promoting polysaccharide 
degradation and formation of SCFAs. It should however be noted that animal studies 
often show that increased fermentable fiber intake is associated with reduced body 
weight gain and/or adiposity, which may also depend on the animals’ phenotype29 
likely due to differences in microbial fermentation capacity. A potential mechanism 
whereby methanogens may affect energy extraction and subsequently lead to overweight 
is through signalling of the G protein-coupled receptor Gpr41, for which SCFAs serve 
as ligands. Gpr41 expressed in the intestine and adipocytes stimulates the expression of 
the adipokine leptin and the intestinal peptide tyrosine-tyrosine (peptide-YY), which 
both influences energy metabolism and appetite level.17 Although, our results were 
in line with the above studies, other studies showed conflicting results compared to 
ours. Million et al.30 found that the gut microbiota of obese humans is depleted in M. 
smithii. Two studies also reported that M. smithii was negatively correlated with BMI.19, 
31 Fernandes et al.23 found that archaea presence was not associated with increased BMI. 
Armougom et al.20  did not find a difference in the abundance of M. smithii in obese 
compared to normal weight individuals. Differences in the methods and designs, such 
as techniques to detect methanogens, sample sizes, geographical settings, and dietary 
habits of the participants might all contribute to these different findings. Moreover, 
our study differs compared to most previous studies with respect to participants’ weight 
status, which is in the normal range for the majority of subjects, and their young age.
We collected faeces from the children at an age where stability of the gut microbiota 
is believed to be achieved and may be comparable to the adult microbiota. A number 
of studies revealed that the childhood microbiota has evolved into an adult-like 
configuration by the age of 2 to 3 years.32-34 Little is known whether the levels of archaea 
present in children are comparable to adults and studies have not yet been done on 
children above 3 years. 
The large sample size and longitudinal design are major strengths of the present study. 
Questionnaires were repeatedly collected during the developmental stages of the 
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children, yielding vast information on anthropometric data over time. The presence of 
detailed and prospective information on background factors enabled the adjustments of 
many confounders, including physical activity and diet. Results showed an independent 
association of archaea with weight outcomes, regardless of such confounding factors.
Our study also has some limitations. Repeated weight and height measurements in our 
study were parent-reported. A study by Scholtens et al., showed that this may lead 
to both an underestimation of the children’s weight and an overestimation of their 
height, resulting in a lower BMI and lower prevalence of overweight.35  Another study 
showed the opposite, that is, an overestimation of weight implying more overweight in 
parent-reported information.36 A validation study using data from the KOALA Birth 
Cohort Study, found an underestimation of overweight was found with parent-reported 
data compared to data collected during home visits.37  Based on this, it is likely that 
anthropometric measurements by well-trained persons may lead to stronger associations 
between BMI and archaea. This may have resulted in an underestimation of the true 
associations. 
Faecal samples of the children were collected only at one time point. We assumed that 
the colonization with archaea in the children is relatively constant over time. Indeed, 
previous studies have shown that the quantities of M. smithii in human faeces remained 
constant over time.38  This trend of stability of M. smithii has also been reported over 
a 13-month period using faecal specimens from two individuals.39  Additionally, a 
comparative analysis of the genome of M. smithii and its transcriptome and metabolome 
in gnotobiotic mice in the absence and presence of B. thetaiotaomicron indicated that M. 
smithii survives in the intestinal tract of the gnotobiotic mice through different survival 
and colonization mechanisms despite the presence of its competitors for substrates.40 
However, future studies are warranted in which faecal samples are collected at different 
time points of anthropometric measurements to accurately assess the change of archaea 
prevalence or counts in an individual over time. This could further establish changes in 
the archaeal microbiota due to different physiological, pathological, and iatrogenic (e.g., 
administration of certain antibiotics) conditions over time. 
In conclusion, this study demonstrates that the presence as well as the higher counts 
of M. smithii in the gut of children at school age is associated with overweight, higher 
weight, and BMI z-scores from 6 to 10 years of age. This finding further supports 
the role of the methanogenic archaea in obesity after controlling for diet and physical 
activity which are the main factors associated with obesity. As such, manipulating the 
intestinal (archaeal) microbiota represents a potential strategy to apply together with 
dietary restrictions and exercise in the control of obesity. So far, little is known about the 
factors that determine archaea colonization in the gut. This indicates a pressing need for 
further research on these determinants of archaeal colonization which may be used to 
control colonization of the gut by archaea in the future. 
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SUPPLEMENTAL MATERIAL
Supplemental information S1: Information on plasmid construction for positive 
controls (found in materials and methods section)
Samples positive for M. smithii and M. stadtmanae were used as template in PCR 
reactions for generating positive controls for each of the targets. Each of the specific 
PCR products was purified using the QIAquick PCR Purification Kit (Qiagen, Hilden, 
Germany), ligated into the pGEM®-T Easy Vector according to the manufacturer’s 
instructions (Promega, Madison, USA) and subsequently transformed into chemically 
competent E. coli K12 DH10β (Top10, Invitrogen), which were grown overnight on 
agar plates containing ampicillin, isopropyl β-D-1-thiogalactopyranoside (IPTG) and 
5-bromo-4-chloro-indolyl-β-D-galactopyranoside (X-gal). Colonies containing the 
desired construct, as observed by blue/white screening, were subsequently transferred 
to culture tubes. After overnight culture, plasmids were isolated and sequences between 
EcoRI restriction sites were determined. Serial dilutions of plasmids with the correct 
insert were then used for the construction of standard curves.
Samples with threshold cycle (Ct)-values <40 for M. smithii and <35 for M. stadtmanae 
were considered positive. Log
10
 DNA copies for a given archaeal species per gram of 
wet weight faeces was calculated for each stool sample from the Ct-values using the 
constructed standard curves. 
To confirm the specificity of both assays, PCR products of a random selection of positive 
samples were sequenced. Upon BLAST search, all sequences matched between 99 – 
100% to target species, confirming specificity of the assays.
Figure S1 (a) and (b). Standard curves for qPCR assays of; (a) M. stadtmanae, and (b) M. 
smithii. Ten-fold serial dilutions of the faecal DNA of M. stadtmanae, and M. smithii were 
used to prepare the standard curves and it showed amplification efficiencies of 1.10 and 0.97 
respectively, with both R2= 0.99.
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Abstract 
Objective: To examine the timing, frequency and type of antibiotic exposure during 
the first 10 years of life in association with (over)weight across this period in a cohort 
of 979 children.
Methods: Within the KOALA Birth Cohort Study, antibiotic exposure was obtained 
from General Practitioners. Anthropometric outcomes (age- and sex-standardized BMI, 
weight, and height z-scores, and overweight) were repeatedly measured at seven time-
points during the first ten years of life. Generalized estimating equations was used for 
statistical analysis.
Results: After adjusting for confounders, children exposed to one course of antibiotics 
compared to none in the first six months of life had increased weight- (adjβ 0.24; 95%CI 
0.03-0.44) and height (adjβ 0.23; 95%CI: 0.0002-0.46) z-scores while exposure to ≥2 
courses during the second year of life was associated with both increased weight (adjβ 
0.34; 95%CI 0.07-0.60), and height z-scores (adjβ 0.29; 95%CI -0.003-0.59). Exposure 
later in life was not associated with anthropometric outcomes. Associations with weight 
z-scores were mainly driven by exposure to broad- (≥2 courses: adjβ 0.11; 95%CI 
0.003-0.22) and narrow-spectrum β-lactams (one course: adjβ 0.18; 95%CI 0.005-0.35) 
during the follow-up period. Antibiotics use was not associated with BMI z-scores and 
overweight.
Conclusions: Repeated exposure to antibiotics early in life, especially β-lactams, is 
associated with increased weight and height, thereby indicating that early antibiotic 
exposure might contribute to the rise in childhood obesity. If causality can be established 
in future studies, this further highlights the need for restrictive antibiotic use and 
avoidance of prescriptions when there is minimal clinical benefit.
Introduction 
The discovery of antibiotics in the 1940s has played an important role in the treatment 
of bacterial infections leading to a substantial reduction in human morbidity and 
mortality.1 The optimal rate of prescribing antibiotics to patients has recently become a 
source of concern due to the fact that over-prescription of antibiotics is a threat to public 
health in terms of costs, increasing antibiotic resistance and frequent side effects.2-4 The 
increase in the overuse of broad-spectrum antibiotics in conditions that could be treated 
with narrow-spectrum agents has also been reported.5 Despite a decreasing trend in 
antibiotic use among children, it is still the age group with the highest consumption 
of antibiotics. Among children, approximately 70% of antibiotics are prescribed for 
upper respiratory infections6, 7 and a large part of these prescriptions are considered 
unnecessary.8 
Antibiotics have been linked to both short- as well as long-term perturbations of the 
actively developing infant gut microbiota. This may have a profound impact on human 
health and disease throughout life, as changes in the gut microbiota during this period 
may disrupt metabolic and immune development.9 The important metabolic role of the 
human gut microbiota, which includes extracting energy from otherwise indigestible 
dietary compounds, highlights the importance of elucidating the impact of antibiotic 
use on childhood weight development. Several studies have shown that antimicrobial 
agents can alter the gastrointestinal microbial diversity and community structure,10-12 
which in turn can lead to modulation of host metabolism,13-15 hence resulting in an 
effect on body weight.9, 16 
The growth promoting effect of antibiotics was first observed in the 1950s where 
domesticated mammalian and avian species were routinely administered sub-therapeutic 
doses of antibiotics to accelerate their weight gain for marketing purposes.17-20 Previous 
studies in humans have shown that early-life exposure to antibiotics may affect weight 
development in children.21-26 The differential effects of various antibiotic classes as well as 
the importance of the timing of exposure on childhood weight development still remain 
largely unanswered.27 Moreover, the majority of previous studies was of cross-sectional 
design or, if longitudinal, did not address the transitional evolution of childhood (over)
weight over an extended period of time. 
The aim of the present study is to evaluate the impact of antibiotic exposure from 
birth until the age of 10 years on height and weight development of Dutch children 
participating in the KOALA Birth Cohort Study. The study focuses on the influence 
of timing of antibiotic exposure, type of antibiotics used, and the number of courses a 
child was exposed to. 
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Materials and Methods 
Subjects and study design 
The current study was conducted within the KOALA Birth Cohort Study, an ongoing 
cohort study in the Netherlands. The design of the KOALA study has been described 
in detail elsewhere.28 Briefly, from October 2000 until December 2002, a total of 
3030 pregnant women were recruited at 34 weeks of gestation. Pregnant women with 
a conventional lifestyle (n=2512) were recruited from an ongoing prospective cohort 
study on pregnancy-related pelvic girdle pain in the Netherlands.29 A second group of 
pregnant women (n=518) with alternative lifestyles with regards to dietary habits (organic 
food choice), child rearing practices, vaccination schemes and/or use of antibiotics 
was recruited through alternative channels, organic food shops, Steiner schools, 
magazines and anthroposophic doctors and midwives. Over time, data was collected 
using questionnaires, during home visits, and by clinical/laboratory examinations. 
A subgroup of 1,793 parents (out of 2,313 asked) gave informed consent to obtain 
information regarding their child’s medication use from General Practitioner (GP) 
records. In 2014, a postal questionnaire was sent to GPs to retrieve this information. 
Finally, 529 out of the 744 contacted GPs provided information on medication used for 
a total of 1,171 children. After excluding premature children (<37 weeks of gestation, 
n=28), twins (n=16), children with congenital abnormalities related to growth (e.g. 
Down’s syndrome, cystic fibrosis, Turner syndrome, and Fallot’s tetralogy, n=12) as well 
as children without detailed information on antibiotic use (n=136), a total sample size 
of 979 children was eligible for further analysis (Figure I).
All children in this study were Caucasians. The study was approved by the Medical 
Ethics Committee of the Maastricht University Medical Center, the Netherlands.
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Study Population in 2014: 
N=979 
Study Base 
Prospective study on pregnancy-related 
pelvic girdle (PPGP) Study N=7020 
Conventional lifestyle Cohort 
N=2512 
Alternative lifestyle cohort 
N=518 
Recruitment of the KOALA Birth 
Cohort Study from 2000-2002 
N=3030 
Children with available information on 
medication usage in 2014 
N=1171 
1793 children were registered with 744 
contacted GPs of which 529 of the GPs 
provided information on medication used for 
a total of 1171 children in 2014: 
Exclusion for analysis: (N=192)  
- Missing detailed information on antibiotic 
use (n=136) 
- Twins (n=16) 
- Prematurity < 37 weeks of gestation (n=28) 
- Congenital abnormalities related to growth 
(n=12) 
 
Time-point 1 (2001): Age 0.9±0.1years 
Response rate: n=903 (92%) 
Time-point 2 (2002): Age 1.8±0.3 years 
Response rate: n=910 (93%) 
Time-point 3 (2006): Age 4.7±0.3 years 
Response rate: n=864 (88%) 
Time-point 4 (2007): Age 6.20.5 years 
Response rate: n=884 (90%) 
Time-point 5 (2008): Age 6.80.5 years 
Response rate: n=808 (82%) 
Time-point 6 (2009): Age 7.80.5 years 
Response rate: n=770 (79%) 
Time-point 7 (2010): Age 8.80.5 years 
Response rate: n=807 (82%) 
Parents were asked for consent regarding 
child’s medication usage in 2006 
N=2313 
Parents who provided written informed 
consent in 2006 
N=1793 
Figure I. Flow chart illustrating how the present study population of 979 children was obtained 
 
Figure I. Flow chart illustrating how the pres nt st y population of 979 children was
obtained
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Antibiotic use
The questionnaires sent to GPs amongst others referred to exposure of the child to oral 
antibiotics over its lifetime, i.e. “Did the child ever use antibiotics” and “If yes, could 
you give the generic drug name and date of each prescription.” In addition, GPs were 
also asked to attach the entire medication history (including generic drug name, and 
date of prescription) of the child from birth onwards. Both sources of information were 
used to determine the antibiotic use of each child. We did not collect information on 
antibiotics administered in hospitals. 
The number of courses of antibiotics prescribed to children in the first 10 years of life 
was analyzed as a categorical variable (none, 1, 2-3, and ≥4 courses). Separate variables 
were subsequently created to examine antibiotic exposure at different ages (first six (0-6) 
months), second six (6-12) months, second (1-2 years), and above the second (>2 years) 
year of life), and to examine the effects of different types of antibiotics prescribed (broad-
spectrum (BS) β-lactams (amoxicillin, cephalosporin), narrow-spectrum (NS) β-lactams 
(flucloxacillin, pheneticillin, phenoxymethylpenicillin), macrolides (erythromycin, 
clarithromycin, azithromycin), antimetabolites (co-trimoxazol, trimethoprim), and 
others (nitrofurantoin, metronidazol, gentamicin, and tetracycline)). Within these 
variables, the number of antibiotic courses (none, 1, and ≥2 courses) was associated 
with anthropometric outcomes.
Data collection and longitudinal outcome measures
Pregnant women received questionnaires at 14 and 34 weeks of gestation, collecting data 
on pre-pregnancy weight, weight gain during pregnancy, maternal education and family 
size. Data from obstetric reports and questionnaires completed by the mothers were 
obtained two weeks after childbirth, with data on gestational age, birth weight, gender, 
mode and place of delivery, smoking during pregnancy and gestational hypertension or 
diabetes. At the children’s age of (mean±standard deviation (SD)) 5.0 ±0.6 years, food 
frequency questionnaires (FFQ) were filled out by the parents to report the dietary 
habits and physical activity of their children. The FFQ was developed and validated 
with the doubly labelled water method to measure energy intake at age 4-6 years.30 
 
Information on the child’s weight, height and age at the time of measurement was 
collected via self-administered questionnaires at seven different points in time. At the 
first two follow-up time points, when the children had attained the age (mean±SD) of 
0.9±0.1 and 1.8±0.3 years, parents were asked to report the most recent height and weight 
measurements including age at measurement (in months) at the Baby Welfare clinics. 
At the other five follow-up points, questionnaires were sent to the parents in which they 
were asked to measure and report the child’s height (cm) and weight (kg, specified to 
one decimal) without clothes or shoes at ages (mean±SD) of 4.7±0.3, 6.2±0.5, 6.8±0.5, 
7.8±0.5, and 8.8±0.5 years respectively. Body Mass Index (BMI = weight/height2 in kg/
m2), height and weight measurements were standardized by recoding them into age- 
and gender-specific z-scores using the Dutch Growth Study31 as a reference population. 
BMI z-scores were used as continuous outcomes as well as dichotomized into “not 
overweight” vs. “overweight” based upon a cut-off z-score ≥1.04 (BMI z-score agreeing 
with the 85th percentile) standardized for age and gender.32
Statistical analysis
Summary statistics of exposure variables and characteristics of the study population 
for children who were exposed and not exposed to antibiotics are presented as mean 
±SD for continuous variables, and numbers and percentages for categorical variables. 
Generalized estimating equations (GEE) models with an autoregressive correlation 
structure were used to analyze the association between antibiotic use and the 7 repeated 
BMI z-scores, weight z-scores, height z-scores (as continuous outcomes), and overweight 
status over time (as a binary outcome). The age of the child at the time of weight and height 
measurement was included in all models as the time variable. We investigated whether 
the association between the main exposures and outcomes differed over time and also if 
this association differed between recruitment groups (alternative and conventional), and 
gender. This was done by entering a time-exposure, a recruitment group-exposure, and 
a gender-exposure interaction term, respectively, in all models. In none of the models 
were these interactions statistically significant (p>0.05). The following a priori potential 
confounders33-35 were included in all adjusted (multivariable) models: recruitment 
group (conventional or alternative), household size, maternal education (low (primary, 
preparatory vocational or lower general secondary schools), middle (vocational, higher 
general secondary or pre-university education), high (higher vocational or academic 
education), or other), maternal pre-pregnancy weight, maternal pregnancy weight gain, 
smoking during pregnancy, gestational diabetes, gestational hypertension, mode and 
place of delivery (vaginal delivery at home, vaginal delivery in hospital, or caesarean 
section in hospital), gender, birth weight, gestational age, duration of breastfeeding, 
child’s dietary intake (total fiber, total energy, fats and carbohydrates both as percentage 
of total energy), and child’s physical activity.
Due to loss to follow-up and incompletely filled out questionnaires, missing values 
in some confounders occurred. To obtain an unbiased and statistically more powerful 
analysis36 we imputed these confounders. We used a Markov Chain Monte Carlo 
(MCMC) method for multiple imputations in SAS to impute missing values: ranging 
from 0.004% missing values for duration of breastfeeding to 0.1% for household size. 
Missing values in categorical confounders were imputed by adding a ‘missing’ category. 
We then performed GEE analyses on the combined imputed datasets (n=10) 
while averaging all parameter estimates for each variable.37, 38 Results from 
the combined imputed datasets were comparable to those of the original 
non-imputed data; hence final results were reported from the imputed data. 
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Data analysis was performed using statistical software packages SAS 9.3 and SPSS 21.0 
(SPSS Inc., Chicago, IL, USA). A pre-selected significance level of p-value <0.05 was 
considered in all analyses.
Results
From the cohort of 1,171 children with information on antibiotic use, a total of 979 
children were eligible for analysis (Figure I). Participant characteristics of the current 
study population and the entire KOALA cohort are presented in Table I. In general, 
the KOALA cohort and the present study population were comparable, although 
the proportion of mothers with a high education level as well as home-born children 
appeared to be slightly higher, and the duration of breastfeeding appeared to be longer 
in the present study population. 
Table I. Participant characteristics of the present study population and the total KOALA 
Birth Cohort Study at start of the follow-up
Covariates
 
KOALA Birth 
Cohort Study
Study  
Population
Exposed Unexposed
(N=3030)
Mean±SD
(N=979)a
Mean±SD
(n=613)
Mean±SD
(n=366)
Mean±SD)
Recruitment group (n (%)) 
Conventional 2512 (81.9) 801 (81.8) 534 (87.1) 267 (73.0)
Maternal education (n (%))b
Low 289 (9.5) 73 (7.5) 54 (8.8) 19 (5.2)
Middle 1062 (35.0) 345 (35.2) 234 (38.2) 111 (30.3)
High 1343 (44.3) 521 (53.2) 300 (48.9) 221 (60.4)
Other 108 (3.6) 30 (3.1) 18 (2.9) 12 (3.3)
Maternal smoking during pregnancy (n (%)) 
yes 200 (6.6) 49 (5.0) 28 (4.6) 11 (3.0)
Maternal pre-pregnancy weight (kg) 67.8±13.1 68.0±12.5 68.4±12.6 67.4±12.2
Maternal pregnancy weight gain (kg) 14.3 ±5.1 14.0±5.0 14.1±5.0 13.9±4.9
Gestational diabetes (n (%))
yes 19 (0.6) 7 (0.7) 7 (1.1) 0 (0.0)
Gestational hypertension
yes 118 (3.9) 48 (4.9) 31 (5.1) 17 (4.6)
Mode and place of delivery (n (%)) 
Vaginally at home 1194 (39.4) 451 (46.1) 270 (44.0) 181 (49.5)
Vaginally in hospital 1149 (37.9) 395 (40.3) 253 (41.3) 142 (38.8)
Caesarean section at hospital 311 (10.3) 107 (10.9) 70 (11.4) 37 (10.1)
Gender (n (%))
Boy 1543 (50.9) 490 (50.1) 314 (51.2) 176 (48.1)
Birthweight (g) 3504 ±512.4 3551.3±454.7 3547±456 3557±453
Gestational age (weeks) 39.8±5.0 39.8±3.0 39.8±3.7 39.8±1.2
Duration of breastfeeding (months) 4.9±4.6 5.4±0.1 4.9±4.1 6.4±4.4
Dietary factors
Total energy intake (kJ) 6173±1249 6181±1277 6186±1245 6173±1330
% energy intake from protein 14.6±2.1 14.6±2.0 14.6±2.0 14.5 ±2.0
% energy intake from carbohydrates 55.8±5.0 55.8 ±4.9 55.8±4.9 55.7±4.9
Fiber (g) 15.3±4.0 15.3±3.8 15.0±3.7 15.7±4.0
Household size 4.3±0.8 4.3±0.8 4.2±0.7 4.4 ±0.8
Physical activity (hrs/week) 9.5±4.5 9.3±4.3 9.3 ±4.4 9.1±4.0
a Totals may not add up to 979 because of missing values (see number of missing values in methods section)
b Maternal education - Low: primary school, preparatory vocational or lower general secondary school, middle: vocational, 
higher general secondary or pre-university education, high: higher vocational or academic education.
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Of the 979 children, 613 (62.6%) children were exposed to at least one antibiotic 
course during follow-up (Table II). Of these 613 children, 127 (13.0%) received 
four or more courses of antibiotics over the entire follow-up period, while 64 (7.0%) 
and 102 (11.7%) were exposed to antibiotics before the age of 6 and 6-12 months 
respectively. The majority of children, 531 (54.5%) were exposed to BS β-lactams, 
whereas macrolides (168; 17.2%), NS β-lactams (72; 7.4%), antimetabolites (37; 
3.8%), and other antibiotics (24; 2.4%) were used less frequently. All children had at 
least one anthropometric measurement available during follow-up (Table III). At time-
point 1 (beginning of follow-up) anthropometric data were available for 896 out of the 
979 children, with 15.1% of the children being overweight. For subsequent follow-up 
time-points anthropometric data were available for 900, 848, 820, 757, 709, and 768 
children, respectively.
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92 When analyzing the number of courses of antibiotics children were exposed to during 
the entire follow-up period, neither the crude nor adjusted models showed significant 
associations with BMI-, weight-, height z-scores (Table II) or overweight (Table IV, 
Supplemental). 
When we subsequently examined antibiotic exposure at different ages, children exposed 
to a single course of antibiotics in the first 6 months of life had higher weight z-scores 
(adjβ 0.24; 95%CI: 0.03 to 0.44) and higher height z-scores (adjβ 0.23; 95%CI: 0.0002 
to 0.46). We found no association for exposure to a single course of antibiotics in the 
second 6 months of life with any of the outcomes. Due to the small group sizes for 
exposure to ≥2 course of antibiotics in the first 6 and second 6 months of life we did not 
find an association with any of the outcomes, although effect sizes were fairly comparable 
to the group exposed to ≥ 2courses of antibiotics in the second year of life. This can 
be confirmed by the fact that, grouping exposure in the first and second 6 months of 
life into exposure in the first year of life, the exposure to ≥ 2courses of antibiotics was 
significantly associated with higher height z-scores. (adjb 0.25; 95%CI 0.04 to 0.46). 
Children exposed to ≥2 courses of antibiotics in second year of life had higher BMI-, 
weight-, and height z-scores compared to children not exposed to antibiotics (Table II). 
These associations in second year of life reached significance with higher weight z-scores 
(adjb 0.34; 95%CI: 0.07 to 0.60) while borderline significant associations were observed 
for BMI (adjb 0.22; 95%CI: -0.02 to 0.46) and height z-scores (adjb 0.29; 95%CI: 
-0.003 to 0.59). No clear associations were observed for risk of being overweight in any 
of the age periods (Table IV; Supplemental). 
With regards to the number of courses of specific types of antibiotics, we found that 
exposure to >2 courses of BS β-lactams over the entire follow-up period was associated 
with significantly increased weight-z-sores (Adjβ 0.11; 95%CI 0.00 to 0.22), while this 
was not the case for children exposed to only one single course of BS β-lactams (Table 
II). In addition, a single course of NS β-lactams during follow-up was associated with 
higher weight z-scores (adjβ 0.18; 95%CI: 0.00 to 0.35) and borderline significantly 
with higher height z-scores (adjβ 0.12; 95%CI: -0.06 to 0.31), compared to children 
not exposed to NS β-lactams during the course of the follow-up. In contrast to these 
observations, exposure to ≥2 courses of NS β-lactam antibiotics was inversely associated 
with height z-scores (adjβ -0.49; 95%CI -0.78 to -0.19), but the number of children 
that had been prescribed multiple courses of NS β-lactams was very small (n=7). The 
same was true for children exposed to ≥2 courses of antimetabolites (adjβ -0.53; 95%CI 
-1.01 to -0.06; n=8). No associations were found for macrolides and other antibiotics 
(metronidazol, nitrofurantoin, gentamicin and tetracycline) with BMI-, weight-, and 
height z-scores. Furthermore, no significant associations were found for any of the 
specific antibiotics with risk of overweight (Table IV; online). 
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Discussion
Within the context of the longitudinal KOALA-study we examined childhood exposure 
to antibiotics (with regards to the timing, type and number of courses) as reported by the 
children’s GPs over an extensive follow-up period from birth up to the age of 10 years. 
Our study demonstrates that antibiotic exposure in early childhood is associated with 
higher weight and height z-scores in children up to 10 years of age, independent of other 
determinants of growth in childhood. Exposure to a single course of antibiotics before 
6 months and exposure to multiple courses of antibiotics between 1-2 years showed the 
most pronounced associations with height and weight z-scores. Also, β-lactams over the 
entire follow-up period was associated with increasing weight z-scores. 
Several studies examined the association between parent-reported antibiotic exposures 
during infancy in relation to BMI or overweight in childhood.24-26 Although these 
studies reported an association between antibiotic exposure and increased weight, these 
associations were sometimes only found in subgroups. Murphy et al.25, only found an 
association between antibiotic exposure and increased weight in boys but not in girls, 
while Asjlev et al. found this association only to be apparent in children from normal 
weight mothers.26 An important limitation of studies using parent-reported antibiotic 
exposure is their inability to distinguish between different types of antibiotics or to 
examine the effect of the number of antibiotic courses children were exposed to. 
Two large GP and prescription registry-based cohort studies examined the association 
between antibiotic exposure within the first two years of life and BMI in early 
childhood.21, 23 These studies were able to elegantly take into account the timing, number 
of prescriptions and the type of antibiotics, while they did not have the possibility to 
control for confounding factors such as habitual diet or physical activity. Both studies 
showed that antibiotic exposure was associated with increased (over)weight, which 
appeared to be most pronounced for exposure to macrolides21 and broad-spectrum 
antibiotics23 respectively.
A recent study by Azad et al, investigated antibiotic exposure in the first year of life, 
as retrieved from prescription records, in association with overweight and adiposity at 
the ages of 9 and 12 years within the context of the Canadian study of Asthma, Genes 
and the Environment (SAGE). According to their findings, infants receiving antibiotics 
in the first year of life were more likely to develop overweight and have higher central 
adiposity in later childhood compared to unexposed infants. These associations only 
remained statistically significant in boys but not in girls after stratifying for gender.22 
Several previous studies indicated the existence of gender differences in the association 
between antibiotic exposure and the anthropometric outcomes.21, 22, 25 However, in our 
study we did not find a statistical significant interaction between antibiotic exposure and 
gender in association with these anthropometric outcomes.
In contrast to these previous studies we were able to take antibiotic exposure over a 
longer period of time (up to the age of 10 years) into account. We however found 
that exposure to antibiotics in the first two years of life, but not exposure over the 
entire follow-up period was associated with weight-related outcomes. A single course of 
antibiotics in the first 6 months of life was already significantly associated with increased 
weight- and height z-scores. This is consistent with the results of Transande et al, who 
found that antibiotic exposure in the first 6 months of life (but not exposure from 6-14 
months) was consistently associated with increased body mass at 10, 20 and 38 months 
of age respectively and overweight at 38 months.2 We however also found that multiple 
courses of antibiotics during the second year of life was associated with increased weight- 
and height z-scores. This could indicate that repeated antibiotic-induced microbial 
perturbations are required to demonstrate an effect on weight development at the age 
when the microbiome starts to become more resilient.
Altogether, our findings support the hypothesis that the time-window in which 
antibiotics can influence weight development appears to be within the first two years 
of life. In a study using a mouse model to mimic pediatric antibiotic use, it was indeed 
shown that therapeutic antibiotic administration accelerates total mass growth and 
progressively changes the microbiome composition and function depending on the 
number of courses and type of antibiotic.39 
Consistent with the findings of Bailey et al.23, in which antibiotic exposure was also 
assessed using medical records obtained from GPs, we found that exposure to b-lactams 
especially repeated exposure to BS β-lactams is associated with increased weight z-scores. 
This association was also seen for exposure to a single course of NS β-lactams but not for 
repeated exposure to NS β-lactams. However, there were only a few children (n=7) who 
were repeatedly exposed to NS β-lactams, hence the lack of statistical power to detect 
associations with regards to weight z-scores. 
Among previous studies conducted with regards to exposure to antibiotics and weight 
development, only one recent study investigated the association of antibiotic exposure 
with height.21 Consistent with our findings they reported an increase in height in children 
exposed to antibiotics (especially penicillins) in the first two years of life as compared 
to unexposed children. Additionally, we found that repeated exposure to both NS 
β-lactams and antimetabolite antibiotics was associated with decreased height z-scores. 
However, since only a few children were prescribed multiple courses of these antibiotics 
(n=7 and n=8, respectively), these findings may be due to chance. Furthermore, little 
is known regarding the associations of b-lactam antibiotics, and antimetabolites with 
anthropometric outcomes hence further studies may be required to replicate these 
findings.
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Although the underlying mechanisms through which antibiotics mediate growth 
promotion is not yet completely understood, it is generally accepted that antibiotic-
induced perturbations of the gut microbiota contributes to these growth-promoting 
effects.15 A study in germ-free mice receiving microbiota transplants of murine donors 
receiving low-dose antibiotics showed an increase in fat mass whereas this was not 
observed in germ-free mice receiving fecal transplants from donors without antibiotic 
exposure.9 This transferability of the growth promotion phenotype indicates that, rather 
than the antibiotics themselves, the antibiotic-induced microbial perturbations play 
a causal role. In addition, some studies also showed that the effects on both growth 
promotion and the ability to convert food calories into body mass was greater for animals 
exposed to antibiotics earlier in life compared to those exposed in later life.19, 40 This 
might explain why antibiotic exposure during early-life has more pronounced effects 
on weight development than exposure in later childhood, since the infant microbiota is 
more susceptible to antibiotic-induced perturbations as compared to the more resilient 
adult-like microbiota that establishes around the age of 2 to 3 years.40-42 
A major strength of our study is that multiple questionnaires were sent over the 
years, which led to comprehensive data on background information enabling the 
adjustment for many determinants of growth development in infancy. Additionally, 
we had 7 occasions of outcome measurements over a time period of 10 years, 
which were together modeled taking into account the correlations between the 
repeated outcome measures within each subject. Moreover, reliable data on 
antibiotic exposure (including timing, type and number of courses) of the children 
were also available over the entire follow-up period as retrieved from GP records. 
As a consequence of the detailed and longitudinal characterization of the participating 
children, the sample size is not as large as several previous studies where information 
on antibiotic exposure was obtained during the first25, 26 and the second21, 23, 24 years 
of life. Although our data on antibiotic use was derived from detailed information on 
prescribed medication in primary healthcare, we did not have information on antibiotics 
prescribed in the hospital and whether the antibiotics prescribed were actually taken by 
the children. However, in the Netherlands, as in most other developed countries, the vast 
majority of antibiotics for childhood infections including infections of the respiratory 
tract, urinary tract and skin are prescribed in primary care.43 As such, underestimation 
of antibiotic exposure is limited. Another potential limitation is the potential bias 
introduced by the fact that weight and height measurements were parent-reported. Even 
though the procedure of measuring weight and height was explained in detail to the 
parents beforehand, parents may tend to over-report body weight in children with a low 
BMI and under-report weight in children with a high BMI hence lower prevalence of 
overweight.44 An underestimation of overweight with parent-reported data compared 
to data collected during home visits was also reported by a validation study of the 
KOALA Birth Cohort Study.45 This may have resulted in an underestimation of the true 
associations as we saw weak associations with BMI z-scores and none with overweight. 
This lack of associations between antibiotic use and overweight might be due to the low 
prevalence of overweight children in our study population and consequently the limited 
statistical power. To control for dietary factors, dietary information was collected only 
once at the age of 5 years using a FFQ. Yet, FFQs are specifically designed to reflect a 
long-term dietary pattern and give a good estimate of habitual dietary intake. Moreover, 
previous studies have shown a relatively stable dietary pattern during childhood.46 Lastly, 
our study population consisted entirely of Dutch Caucasian children hence results might 
not be generalizable to children with another ethnic or racial background.
We did not take the indication for which antibiotics were prescribed into account and 
therefore confounding-by-indication cannot be completely ruled out. 47 Confounding-
by-indication occurs when the indication for which the antibiotics are prescribed, rather 
than the antibiotics themselves, are causally related to weight development. However, 
this is unlikely to explain our results, as multiple infectious episodes in early infancy are 
more likely associated with decreased rather than increased weight.48 
In conclusion, our study among Dutch Caucasian children supports previous evidence 
that repeated childhood exposure (in terms of number of courses) to antibiotics, 
especially BS β-lactams, leads to perturbations of the gut microbiota and subsequent 
weight development in children. Our findings imply that exposure below 2 years of age 
is a critical time in which antibiotics influence the gut microbiota and thus metabolism 
as we saw that antibiotic exposure above 2 years of age has little effect on growth 
development over time. Given the high antibiotic prescription rates in early childhood 
and the growing pandemic of overweight and obesity in western children, further 
research is needed to identify long-term implications in adulthood, and to determine 
the exact mechanisms of this association.
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Table IV. GEE results showing associations of antibiotic exposures (number of courses, type, 
and period) with the risk of being overweight during the first 10 years of life
Overweight
Unadjusted ORa 
(95% CI)
P-value Adjusted ORb 
(95% CI)
P-valuec
Number of courses during follow-up n
none 366 1 (Reference) 1 (Reference)
1 259 1.22 (0.85 to1.75) 0.275 1.09 (0.76 to 1.57) 0.640
2 to 3 221 1.26 (0.88 to 1.80) 0.209 1.13 (0.79 to 1.63) 0.506
≥4 127 1.13 (0.72 to 1.79) 0.598 1.03 (0.66 to 1.60) 0.891
No. of courses of antibiotics by age period
First 6 months of life 
none 910 1 (Reference) 1 (Reference)
1 54 1.23 (0.79 to 1.91) 0.252 1.21 (0.78 to 1.87) 0.396
≥2 10 1.13 (0.39 to 3.29) 0.843 1.19 (0.38 to 3.74) 0.762
6-12 months of life
none 872 1 (Reference) 1 (Reference)
1 86 1.34 (0.81 to 2.20) 0.361 1.40 (0.81 to 2.42) 0.223
≥2 16 1.15 (0.29 to 4.54) 0.821 0.83 (0.26 to 2.67) 0.754
Second year of life (1-2yrs)
none 804 1 (Reference) 1 (Reference)
1 140 0.88 (0.58 to 1.33) 0.536 0.96 (0.63 to 1.46) 0.859
≥2 30 1.25 (0.66 to 2.37) 0.488 1.14 (0.61 to 2.13) 0.676
Above second year of life (>2yrs)
none 438 1 (Reference) 1 (Reference)
1 266 1.33 (0.95 to 1.85) 0.092 1.21 (0.87 to 1.70) 0.263
≥2 260 1.14 (0.81 to 1.60) 0.464 1.02 (0.73 to 1.43) 0.890
No. of courses by type of antibiotic
No. of observations=5661
BS β-lactamsd
none 437 1 (Reference) 1 (Reference)
1 269 1.02 (0.73 to 1.44) 0.892 0.95 (0.68 to 1.34) 0.790
≥2 262 1.28 (0.92 to 1.78) 0.148 1.20 (0.86 to 1.67) 0.278
NS β-lactamsd
none 902 1 (Reference) 1 (Reference)
1 65 1.03 (0.59 to 1.79) 0.918 1.00 (0.57 to 1.76) 0.986
≥2 7 0.32 (0.05 to 2.14) 0.240 0.41 (0.06 to 2.63) 0.347
Macrolided
none 806 1 (Reference) 1 (Reference)
1 116 1.39 (0.97 to 2.00) 0.073 1.29 (0.89 to 1.86) 0.178
≥2 52 0.74 (0.42 to 1.32) 0.309 0.64 (0.35 to 1.16) 0.140
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none 937 1 (Reference) 1 (Reference)
1 29 0.82 (0.33 to 2.05) 0.674 0.83 (0.33 to 2.11) 0.699
≥2 8 0.69 (0.19 to 2.51) 0.569 0.67 (0.19 to 2.31) 0.524
Othersd
none 1 (Reference)  1 (Reference)
1 15 1.65 (0.55 to 5.02) 0.374 1.62 (0.52 to 5.06) 0.407
≥2 9 0.57 (0.20 to 1.68) 0.310 0.50 (0.21 to 1.20) 0.119
aOdds ratio (OR)=ecrude(β)  or eadjusted(β)
bAdjusted for; recruitment group (conventional or alternative lifestyle), household size, maternal level of education (low, 
middle, high and others), maternal pre-pregnancy weight, maternal pregnancy weight gain, smoking during pregnancy 
(yes/no), gestational diabetes, gestational hypertension, place and mode of delivery, gender, birthweight, gestational 
age, duration of breastfeeding, dietary intake (total fiber, total energy, fats and carbohydrates both as percentage of total 
energy), child’s physical activity, and child’s ages during anthropometric measurements.
cColumn represents p-values for the adjusted analysis
dBroad-spectrum β-lactams (amoxicillin, cephalosporin), narrow-spectrum β-lactams (flucloxacillin, pheneticillin, 
phenoxymethylpenicillin), macrolides (erythromycin, clarithromycin, azithromycin), antimetabolites (co-trimoxazol, 
trimethoprim), and others (nitrofurantoin, metronidazol, gentamicin, and tetracycline).
Table IV. (Cont.)
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Abstract
Objective: The present study aimed to identify developmental trajectories of BMI 
z-scores in healthy children from 6-10 years of age; evaluate the relation of the 
trajectories with established risk factors of childhood overweight; and finally reduce the 
high dimensional data of the gut microbiota in association with the trajectories. 
Methods: A total of 295 Dutch children from the KOALA Birth Cohort Study were 
included in this study. Group-based trajectory modelling (GBTM), a method that 
facilitates the identification of distinct longitudinal developmental patterns was applied 
to BMI z-scores measured over four time points. Multinomial logistic regression (MLR) 
was used to investigate the association between established risk factors of overweight 
(total energy intake (KJ), total physical activity (hours/week)) and the trajectories, while 
univariate MLR and Random Forest (RF) were used as methods for data reduction.
Results: Four distinct BMI z-score trajectories were identified: (i) underweight (15.6% 
of the children), (ii) low-normal weight (44.1%), (iii) high-normal weight (34.3%) 
and (iv) overweight (6.1%). BMI as measured by trained research assistants at baseline 
was positively associated with the BMI trajectories (P = <0.0001). An increase in total 
energy intake was associated with a higher likelihood of falling into the overweight 
trajectory (P = 0.026) while an increase in total physical activity was associated with a 
lower likelihood of falling into both the underweight (P=0.002) and low-normal weight 
(P=0.047) trajectories. An increase in bacterial diversity was associated with a lower 
likelihood of falling into both the underweight (adjOR 0.09; 95%CI 0.01 to 0.64) and 
overweight (adjOR 0.06; 95%CI 0.00 to 0.84) trajectories. Data reduction by means of 
univariate MLR led to the identification of 10 bacterial groups that were associated with 
the trajectories (FDR corrected p < 0.25). RF was unable to classify the trajectories in 
association with the gut microbiota with regards to our data.
Conclusion: The present study illustrates how the identification of unique patterns of 
childhood growth development by means of GBTM might be used to study the role of 
the microbiome in weight development within the context of longitudinal studies. 
Introduction
Over the past decade, the evidence for a role of the gut microbiota in childhood overweight 
has been rapidly increasing.1 The human gut microbiota is a complex community, 
consisting of approximately 100 trillion bacteria belonging to hundreds of different 
species, next to numerous viruses, archaea, fungi and protozoa.2 The composition of 
the gut microbiota also varies significantly between individuals.3 The high diversity and 
dimensionality of data from this ecosystem complicates the identification of relevant 
microbial candidates that may be associated with childhood overweight and in addition 
impedes drawing valid biological inferences. Further complications arise when weight 
fluctuations which differ within and between children during childhood development 
need to be taken into consideration. Hence, the application of statistical approaches for 
data reduction and variable selection with regards to repeatedly measured multinomial 
dependent variables could help in tackling this challenge.
Previous studies conducted so far [reviewed in4] on the association between the gut 
microbiota and weight development mainly used traditional methods such as linear and 
logistic regressions to link the presence and abundance of a variety of microbial taxa to 
childhood overweight at fixed time points (cross-sectional studies). However, childhood 
height and weight development is pulsatile, in which periods of rapid growth (“growth 
spurts”) are separated by periods of no measurable growth. The few longitudinal 
studies that have taken such fluctuations into account considered associations between 
microbiota and weight gain (increases in BMI) over a defined period of follow-up using 
generalised linear mixed models for longitudinal data.5-7 This approach assumes that 
the children form a homogenous group without considering the fact that there may be 
distinct patterns of weight development during childhood. 
A number of studies have been performed identifying distinct BMI trajectories in 
children using group-based trajectory modelling (GBTM).8-10 GBTM, a model-based 
clustering method (a person-centred approach) was developed to identify groups of 
individuals following a similar developmental pattern of a certain entity in a longitudinal 
setting.11,12 Using this approach, researchers are able to understand how life-course 
experiences unfold at the individual level, hence clustering individuals with similar 
developmental patterns. The growth trajectories created in previous studies were used to 
investigate their associations with antenatal and postnatal risk factors8-10. 
So far no study has been performed to associate high dimensional data, such as 
comprehensive measures of the gut microbiota, to childhood weight developmental 
trajectories. Altogether, to examine the association between the gut microbiota and 
childhood weight development, a combination of statistical methods is required that 
can capture the heterogeneity in growth patterns during childhood, and enable the 
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reduction of the high dimensional microbial data to a limited number of bacterial 
candidates that are potentially associated with these trajectories. Using data of children 
from the KOALA Birth Cohort Study with anthropometrics measured repeatedly from 
6 to 10 years of age, we sought to: 1) identify developmental patterns of BMI z-scores 
(also known as latent trajectories); 2) validate these trajectories with variables known 
to be associated with overweight; and 3) use existing statistical methods for variable 
selection/reduction (univariate logistic regression, and Random Forest (RF)) to identify 
bacterial groups of the gut microbiota associated with these trajectories. 
Methods
Study design and participants
Data were obtained from the prospective KOALA Birth Cohort Study in the 
Netherlands, whose design has been described in detail elsewhere.13 Briefly, a total of 
2,834 pregnant women were recruited, at 34 weeks of gestation, from October 2000 
until December 2002. A subgroup of 1,204 parents was asked for consent for a home 
visit for anthropometric measurements and to collect a single faecal sample from the 
child at the age of 6-7 years. This subgroup comprised of participants who had home 
visits for blood collection from the mother during pregnancy and/or the child at age 2 
years, and who were still active participants (Figure 1). Faecal samples were obtained 
from 669 children. Exclusion criteria for the current study were: prematurity (infants 
born before 37 weeks of gestation), twins, abnormalities linked to growth (such as 
Down’s syndrome, Turner syndrome, Fallot’s tetralogy, multiple disabilities, and cystic 
fibrosis), faecal samples with transport times exceeding 3 days, or lack of data on dietary 
intake. A total of 295 children that met these criteria were included in the present 
study; all being Caucasians. Written informed consent was given by all parents, and the 
study was approved by the Medical Ethics Committee of Maastricht University and the 
National Ethical Committee for Medical Research.
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Figure 1: Flowchart of the study population 
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Data collection and outcome measures
Faecal sample collection
Parents collected faecal samples of their children using faeces tubes with spoons attached 
to their lids (Sarstedt, Nümbrecht, Germany). Samples collected were mailed to the 
laboratory, 10-fold diluted in peptone/water (Oxoid CM0009) containing 20% (vol/
vol) glycerol (Merck, Darmstadt, Germany) upon arrival, and stored at -80oC until 
further analysis.
Microbiota profiling
Faecal DNA isolation has been described in detail elsewhere.14,15 Briefly, faecal DNA from 
295 faecal samples was isolated using a combination of Repeated-Bead-Beating (RBB) 
plus column purification method. A Nanodrop 1000 spectrophotometer (Thermo 
Fisher Scientific, Wilmington, USA) was used to determine DNA concentration 
and purity. Faecal DNA was then stored at -20oC pending microbial analyses. The 
intestinal microbiota composition was assessed using the Human Intestinal Tract 
Chip (HITChip).16 This is a phylogenetic profiling DNA microarray containing over 
4,800 probes and targeting the V1 and V6 hypervariable regions of 16S rRNA gene. 
The array detects over 1,033 species-like bacterial phylotypes (>98% 16S rRNA gene 
sequence similarity) that represent the majority of the bacterial diversity of the human 
intestinal tract.16 The full-length 16S rRNA gene was amplified after DNA extraction, 
followed by in vitro transcription and labelling of the resultant RNA with Cy3 and Cy5 
before hybridization to the array. Each sample was hybridized in duplicate to ensure 
reproducibility, and raw signal intensities were normalised as previously described.17 For 
the data analysis, hybridization signals were summarized to 130 genus-like phylogenetic 
groups (>90% 16S rRNA gene sequence similarity) referred to as species and relatives, 
the latter being shortened as ‘et rel.’.16 A list of these 130 genus-like levels has been 
reported elsewhere.17 The log10-transformed signals were used as a proxy for bacterial 
logarithmic abundance. Diversity of the microbiota was quantified using Shannon’s 
diversity index based on non-logarithmic oligo-level signals as implemented by the R 
package vegan18 while richness was obtained by counting the total number of probes in 
each sample using an 80% quantile threshold for detection.
Anthropometric measures
Height (in cm) without wearing shoes and clothes, and weight (in kg) of the children 
at ages (mean±SD) of 6.0±0.3, 6.8±0.2, 7.7±0.3, and 8.8±0.4 years were reported by 
their parents through the use of self-administered questionnaires. These ages at BMI 
measurements will further be referred to as time-points 1-4, respectively. For each 
time-point BMI was calculated as weight divided by height squared (kg/m2). BMI 
measurements were then converted into age- and gender-specific z-scores using the 
Dutch National growth study19 as the reference population. The BMI z-scores were 
subsequently used as input for the Group-Based Trajectory Modelling.
In a subgroup of children (n=712) including the 295 children in this present study, height, 
and weight, were also measured during home visits by trained research assistants at the 
age of 6–7 years, with the children wearing only their underwear. Height was measured 
with a portable stadiometer (Leicester height measure), and weight was measured with a 
digital scale (HE-5, CAS Corp., East Rutherford, NJ, USA) and recorded in millimetres 
and grams (rounded off to 100 g), respectively. The height and weight measurements 
during the home-visits were also converted into BMI z-scores, but were not used for the 
Group-Based Trajectory Modelling.
Other measures
Physical activity: When the child was between 4-5 years of age, parents were asked to 
fill out a questionnaire about the physical activity level of their child during the last 4 
weeks. The questions included: “How many times a week does your child exercise in 
school or a sports club?” and “How many days a week does your child play outside?” 
They could respond by indicating either of the following “never or less than 1 day a 
week,” “1 day a week,” “2 days a week,” “3 days a week,” “4 days a week,” and “5 days a 
week or more.” Furthermore, the duration of these activities was asked. The number of 
hours of physical activity per week was calculated from these answers.
Total energy intake: The average energy intake (kJ) per day at 4-5 years of age was obtained 
through the use of Food Frequency Questionnaires (FFQ) specifically developed to 
assess children’s energy intake and validated by using the doubly labelled water method. 
The questionnaire consisted of 71 items and, in addition, for 27 foods the specific types 
or brands consumed and preparation methods were asked. Parents reported their child’s 
habitual food consumption by indicating the frequency of consumption (“never” to 
“6–7 days a week”) and by specifying proportion sizes in natural units (for example, 
pieces, slices), household units (for example, glasses of spoons) or grams (for example, 
grams of fish). Additionally, parents were asked to measure the volumes of the cups and 
glasses they used for the children. The average energy intake (kJ) per day was calculated 
with the aid of the Netherlands Food Composition Table 2001 (NEVO).20 A dietician 
provided nutritional values for the products that were not included in the NEVO 2001 
table.
Statistical Analysis
Statistical analyses involved a series of sequential steps summarized in the flow-diagram 
(Figure 2). Briefly, the first part concerned the identification of BMI developmental 
trajectories with GBTM. The second part aimed at linking the extracted latent 
trajectories to established risk factors of childhood overweight (total energy intake (KJ), 
total physical activity (hours/week)) and BMI measured by trained research nurses 
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during home visit at baseline (6-7 years of age). Methods for variable selection and 
reduction (univariate multinomial baseline-category logistic regression and random 
forest) were then used to reduce the high dimensional data of the gut microbiota at 6-7 
years of age while linking it to the BMI developmental trajectories.
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Figure 2. Schematic overview of methods used for statistical analysis in this present study   
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Figure 2. Schematic overview of methods used for statistical analysis in this present study 
Group-Based Trajectory Modelling (GBTM)
Distinctive BMI z-score developmental trajectory patterns across time-point 1 to time-
point 4 were identified by fitting a group-based trajectory model also known as latent 
class growth analysis or semi-parametric finite mixture modelling (shown in Figure 2)21 
using PROC TRAJ in SAS.22,23 This analytical method was developed to identify groups 
of individuals following a similar pattern of a certain characteristic during a defined 
follow-up period. Compared to the traditional latent growth curve modelling which 
assumes the random parameters to be normally distributed, group-based trajectory 
modelling assumes a number of discrete underlying groups in the population with 
each having its own estimated population prevalence, intercept (starting BMI z-scores 
value) and slope (i.e. the change of BMI z-scores across time points).21 Model selection 
followed a two-step approach: first the number of latent trajectories was established 
(class-enumeration), and then the order of the polynomials affecting the trajectories’ 
level and shape was determined (given 4 time-points, polynomials up to cubic order 
were considered).12,21 To assess class-enumeration we employed a supportive R-code that 
compiles several fit-indices for several models with different number of latent classes 
into automated graphical displays (Fit-criteria Assessment Plots – F-CAP).24 Model-
adequacy indices11 were the Bayesian Information Criterion (BIC), Akaike Information 
Criterion (AIC), the average posterior probability of assignment (APPA), odds of correct 
classification (OCC), mismatch between estimated and assigned group probabilities, 
standard deviation of group membership probabilities (SD-GMP), and the percentage 
of individuals estimated to be assigned to the smallest latent group. For the latter, a cut-
off point of 1% was applied.
After obtaining the most appropriate number of trajectories, we carried out stratified 
analysis by gender by applying the final model to both strata. They were similar in 
their trajectory shapes but differed in their trajectory group proportions. Hence, due 
to the small sample size and to increase power, further analysis was performed without 
stratifying for gender. After determining the number of latent trajectories, children 
were assigned to one of the uncovered latent classes, based on the maximum posterior 
probability of assignment.21 This latent trajectory classification was used as the outcome 
for subsequent model validation. Multinomial baseline-category logistic regression 
models were fitted to examine whether the latent trajectories corresponded with 
established risk factors for childhood overweight (physical activity, total energy intake, 
and BMI z-scores measured at home visit). In addition, several studies have indicated 
a lower richness/diversity of the gut bacterial communities in subjects with obesity and 
overweight compared to normal weight individuals.25-27 We therefore examined the 
association between microbial richness and diversity and BMI z-score trajectories.
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Random forest
Random Forest (RF), a supervised machine learning technique which is well-suited 
for large data sets with many features,28 was used to identify bacterial groups that 
differentiate gut microbiota composition in children at age 6-7 years with regards to 
the four BMI z-scores trajectories generated. RF in principle allows determining non-
linear relationships and combinatorial relations of bacterial groups (e.g. a combination 
of two bacterial groups better separates classes than either bacterial group on its own) 
with the four BMI z-score trajectories. RF implemented in the statistical programming 
R package, randomForest29 was used as described earlier30 where a classification forest 
was trained with 500 decision trees each. By default, RF trains a particular tree based 
on 63% of the samples and uses the remaining 37% of the samples to determine its 
classification accuracy. In this study, implementation of RF feature elimination allowed 
removing features irrelevant or even confusing to the classification to (i) reduce the 
number of features and (ii) potentially reduce the classification error of the dataset with 
reduced numbers of features.
Multinomial baseline-category logistic regression
To compare the performance of RF in identifying potential bacterial groups among the 
130 that can potentially discriminate between the different classes of the trajectories, 
we performed a univariate analysis of each microbial group. This was done by fitting 
a univariate multinomial logistic regression model to obtain p-values for each bacterial 
group. To correct for multiple testing (adjusting p-values for the number of hypothesis 
tests performed), we applied the false discovery rate (FDR) approach of Benjamini-
Hochberg using PROC MULTEST in SAS.31 In order not to miss out important 
microbial groups which could be associated with the trajectory groups we decided to 
consider a 25% (0.25) FDR for the adjusted p-values.32 This is because more traditional 
levels such as 0.05 can fail in identifying relevant microbial groups in exploratory 
analyses such as these.33
Except for RF, all analyses were conducted using SAS V.9.3 (SAS Institute, Cary, North 
Carolina, USA). The statistical significance level was set to a<0.05.
Results
A total of 295 children were eligible for analysis (Figure 1). Characteristics of the study 
population and across the different trajectories are presented as means and standard 
deviation (SD) for continuous variables or as absolute numbers and percentages for 
categorical variables (Table 1). In the present study, BMI z-score measurements were 
available for 212 (72%) children at time-point 1, 190 (64%) at time-point 2, 224 (76%) 
at time-point 3 and 245 (83%) at time-point 4. The model fit statistics for GBTM to 
identify the optimal number of distinct trajectories of BMI z-scores in the present study 
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According to the BIC criterion, which is the most commonly applied, the best-fit model was 
the one with six trajectories (Supplementary Figure 1). However, in order to obtain a 
reasonable number of children in each trajectory group and to improve the power for 
subsequent analysis, we decided to use the more parsimonious four-group trajectory model. 
The four group model also performed well on the other model adequacy indices: the 
(minimum) APPA of the latent groups was 0.80 (Figure 3b), well above the acceptability 
threshold of 0.70, and OCC was above 10 (Figure 3c), again much larger than the 
acceptability threshold of 5. The proportion of individuals belonging to the smallest group 
among the trajectory groups is illustrated in Figure 3d.
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Figure 3. From a to d; AIC, BIC (calculated as; BIC= Log(L) – p.log(N)) and L (a); APPA, mismatch and SD 
(b); OCC (c) and percentage of individuals estimated to be assigned to the smallest group (d). Ten models for 
BMI z-score developmental pattern were fitted (x-axis). The number of latent groups, k=4 was selected.
Based on the highest posterior probability of assignment, children were classified into one of 
these four groups (n=46, 15.5% for the first trajectory group; n=130, 44.1% for the second 
group; n=101, 34.4% for the third group; and n=18, and 6.1% for the fourth group (Figure 4)). 
In labelling the trajectories, the following cut-offs were considered as z-scores; underweight 
(BMI z-scores<-1.64), healthy or normal weight (BMI z-scores 1.64 and 1.03), and 
overweight (BMI z-scores≥1.04). These cut-offs correspond to respectively the <5th
percentile, 5th to 85th percentiles, and ≥85th percentile, respectively, of the World Health 
Organisation reference population.34 Trajectory 1 consisted of children who were underweight 
over the entire follow-up period; hence this group was labelled as “underweight”. The BMI z-
score values for trajectories 2 and 3 during the period of follow-up were all within the normal 
range for healthy weight with a BMI range between -1.64 and 1.04; hence these groups were 
0.0%
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1
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OCC -
 Percentage of individuals belonging to the smallest group
Figure 3. From a to d; AIC, BIC (calculated as; BIC= Log(L) – p.log(N)) and L (a); APPA, 
mismatch and SD (b); OCC (c) and percentage of individuals estimated to be assigned to the 
smallest group (d). Ten models for BMI z-score developmental pattern were fitted (x-axis). 
The number of latent groups, k=4 was selected.
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are presented in Figure 3 (a to d). According to the BIC criterion, which is the most 
commonly applied, the best-fit model was the one with six trajectories (Supplementary 
Figure 1). However, in order to obtain a reasonable number of children in each trajectory 
group and to improve the power for subsequent analysis, we decided to use the more 
parsimonious four-group trajectory model. The four group model also performed well 
on the other model adequacy indices: the (minimum) APPA of the latent groups was 
0.80 (Figure 3b), well above the acceptability threshold of 0.70, and OCC was above 
10 (Figure 3c), again much larger than the acceptability threshold of 5. The proportion 
of individuals belonging to the smallest group among the trajectory groups is illustrated 
in Figure 3d.
Based on the highest posterior probability of assignment, children were classified into 
one of these four groups (n=46, 15.5% for the first trajectory group; n=130, 44.1% for 
the second group; n=101, 34.4% for the third group; and n=18, and 6.1% for the fourth 
group (Figure 4)). In labelling the trajectories, the following cut-offs were considered 
as z-scores; underweight (BMI z-scores<-1.64), healthy or normal weight (BMI z-scores 
1.64 and 1.03), and overweight (BMI z-scores≥1.04). These cut-offs correspond to 
respectively the <5th percentile, 5th to 85th percentiles, and ≥85th percentile, respectively, 
of the World Health Organisation reference population.34 Trajectory 1 consisted of 
children who were underweight over the entire follow-up period; hence this group was 
labelled as “underweight”. The BMI z-score values for trajectories 2 and 3 during the 
period of follow-up were all within the normal range for healthy weight with a BMI 
range between -1.64 and 1.04; hence these groups were labelled as, “low-normal weight” 
and “high-normal weight” groups, respectively. Finally, the fourth trajectory group 
represents children who consistently had BMI z-scores above the cut-off for overweight 
throughout the follow-up period and was therefore characterized as the “overweight” 
group.
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labelled as, “low-normal weight” and “high-normal weight” groups, respectively. Finally, the 
fourth trajectory group represents children who consistently had BMI z-scores above the cut-
off for overweight throughout the follow-up period a d w s therefore character zed as the 
“overweight” group.
Time-point
Trajectories:
Size (%)
T1
Observed mean 
SD*
T2 
Observed mean 
SD*
T3
Observed mean  SD*
T4
Observed mean  SD*
1: 146 (15.5) -1.63  0.66 -1.60  0.53 -1.43  0.61 -1.27  0.67
2: 130 (44.1) -0.56  0.44 -0.57  0.41 -0.57  0.49 -0.51  0.43
3: 101 (34.3) 0.35  0.47 0.35  0.50 0.36  0.50 0.57  0.45
4: 18 (6.1) 1.72  0.51 1.51  0.48 1.67  0.47 1.72  0.28
Figure 4: BMI z-scores trajectories over 4 time periods. 1= underweight; 2 = Low normal 
weight group; 3 = High normal weight group; and 4= overweight. Dotted lines below and 
above each trajectory line represent the lower and high 95% confidence bands respectively.
*Means and SDs for trajectories at each time point calculated from the raw (original) data
As compared to the other trajectories, the overweight group appeared to have more male 
children (Table 1). Birthweight of the children appeared to increase across the four 
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Trajectories:
Size (%)
T1
Observed mean 
± SD*
T2 
Observed mean 
± SD*
T3
Observed mean 
± SD*
T4
Observed mean 
± SD*
1: 146 (15.5) -1.63 ± 0.66 -1.60 ± 0.53 -1.43 ± 0.61 -1.27 ± 0.67
2: 130 (44.1) -0.56 ± 0.44 -0.57 ± 0.41 -0.57 ± 0.49 -0.51 ± 0.43
3: 101 (34.3) 0.35 ± 0.47 0.35 ± 0.50 0.36 ± 0.50 0.57 ± 0.45
4: 18 (6.1) 1.72 ± 0.51 1.51 ± 0.48 1.67 ± 0.47 1.72 ± 0.28
Figure 4: BMI z-scores trajectories over 4 time periods. 1= underweight; 2 = Low normal 
weight group; 3 = High normal weight group; and 4= overweight. Dotted lines below and 
above each trajectory line represent t lower and high 95% confidence bands spectively.
*Means and SDs for trajectories at each time point calculated from the raw (original) data
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As compared to the other trajectories, the overweight group appeared to have more 
male children (Table 1). Birthweight of the children appeared to increase across the four 
trajectories. Mothers from the two normal-weight trajectories appeared to be more often 
highly educated compared to the underweight and overweight group. As expected, the 
average BMI based upon height and weight measurements by trained research assistants 
around the time of faecal sampling corresponded to the respective, questionnaire-
based, latent trajectories (Table 1). Total physical activity was lower in children in the 
underweight group. In the overweight group, total energy intake was higher compared 
to the other three trajectories (Table 1). The distributions of BMI at home-visit, total 
physical activity and energy intake across the 4 trajectories are further illustrated in 
Supplementary Figure 2 (a – c). 
Associations between these three variables with childhood BMI z-score trajectories are 
presented in Table 2. Taking the high-normal weight trajectory group as the reference 
group, an increase in BMI z-scores measured at baseline during home visit as well as 
an increase in physical activity were both associated with a lower likelihood of falling 
into the underweight (p= <0.0001 for BMI z-score and p=0.002 for physical activity) 
or low-normal weight trajectories (p= <0.0001 and p=0.047, respectively, Table 2). 
As expected, an increase in total energy intake was associated with a lower likelihood 
of falling into the underweight and low-normal weight group compared to the high-
normal weight reference group. This only approached borderline significance for the 
low-normal weight group (p=0.066). An increase in BMI measured at home visit as well 
as an increase in total energy intake was associated with a higher likelihood of falling in 
the overweight trajectory (p=<0.0001, and 0.026, respectively).
Considering variables characterising the gut microbiota, an increase in bacterial diversity 
was associated with a substantially lower likelihood of being in either the underweight 
(adjOR 0.09; 95%CI 0.01 to 0.64) or in the overweight trajectory (adjOR 0.06; 95%CI 
0.00 to 0.84) (Table 2). An increase in bacterial richness was associated with a slightly 
lower likelihood of being in the underweight trajectory (borderline: adjOR 0.71; 95%CI 
0.50 to 1.01) compared to the high-normal weight trajectory. Altogether this indicates 
that both children in the underweight and overweight trajectories are characterised by a 
lower microbial diversity.
Table 1. Baseline characteristics of study participants in the present study across 
trajectories
Study popu-
lation
N=295a
Mean ± SDb
Underweight 
trajectory
N = 46
Mean ± SDb
Low-normal 
trajectory
N = 130
Mean ± SDb
High-normal 
trajectory
N = 101
Mean ± SDb
Overweight 
Trajectory
N = 18
Mean ± SDb
Gender: n (%)
Male 148 (50.2) 21 (45.7) 70 (53.8) 45 (44.6) 11 (61.1)
Female 147 (49.8) 25 (54.3) 60 (46.2) 56 (55.4) 7 (38.9)
Maternal educational 
level: n (%)
Low 21 (7.2) 2 (4.8) 8 (6.3) 11 (11.0) 0 (0.0)
Middle 113 (38.8) 18 (42.9) 50 (39.4) 36 (36.0) 9 (60.0)
High 157 (54.0) 22 (52.4) 69 (54.3) 53 (53.0) 6 (40.0)
Birth weight (g) 3605 ± 466 3337 ± 441 3583 ± 447 3728 ± 492 3761 ± 443
Variables used for validat-
ing trajectories
BMI z-score at home visit -0.2 ± 0.9 -1.1 ± 0.5 -0.5 ± 0.5 0.4 ± 0.6 1.7 ± 0.5
Total energy intake (KJ) 6180 ± 1217 6040 ± 1261 6018 ± 1191 6310 ± 1170 7046 ± 1220
Total physical activity 
(hrs/week)
9.4 ± 4.5 7.8 ± 3.6 9.2 ± 4.4 10.4 ± 4.7 9.6 ± 4.8
Age at faecal sample  
collection (months)
87.9 ± 9.6 86.9 ± 7.6 90.0 ± 10.1 86.6 ± 9.6 90.4 ± 8.9
Exposure Variables
Richness 6.2 ± 1.0 5.8 ± 1.3 6.4 ± 1.0 6.2 ± 0.9 5.8 ± 0.8
Diversity 5.9 ± 0.2 5.8 ± 0.3 5.9 ± 0.2 5.9 ± 0.1 5.8 ± 0.2
Time of last antibiotic 
course prior to home visit: 
n (%)
No antibiotic use in the 
previous year
248 (85.2) 36 (80.0) 118 (90.8) 81 (81.8) 13 (72.2)
Greater than 4 weeks ago 36 (12.4) 6 (13.3) 11 (8.4) 15 (15.2) 4 (22.2)
Less than 4 weeks ago 7 (2.4) 3 (6.7) 1 (0.8) 3 (3.0) 1 (5.6)
aTotal may not sum up to 295 respectively due to missings.
bValues are mean (standard deviation), unless indicated otherwise.
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Table 2: Multinomial (baseline category) logistic regression results for the association of 
overweight-related factors, bacterial richness and diversity with BMI z-score trajectories
Trajectory group OR [95%CI]* P-value
Validation parameter
BMI z-scores at home visit Underweight
Low-normal weight
High-normal weight
Overweight
0.002 [<0.001 to 0.01]
0.02 [0.01 to 0.05]
1 (reference)
62.97 [10.29 to 385.53]
<.0001
<.0001
<.0001
Total energy intake (KJ/day)ϒ Underweight
Low-normal weight
High-normal weight
Overweight
0.30 [0.05 to 1.95]
0.28 [0.07 to 1.09]
1 (reference)
18.59 [1.41 to 244.74]
0.212
0.066
0.026
Total physical activity (hrs/week) Underweight
Low-normal weight
High-normal weight
Overweight
0.87 [0.79 to 0.95]
0.94 [0.89 to 1.00]
1 (reference)
0.96 [0.86 to 1.07]
0.002
0.047
0.481
Exposure variables
Diversity Underweight
Low-normal weight
High-normal weight
Overweight
0.09 [0.01 to 0.64]
1.92 [0.37 to 10.05]
1 (reference)
0.06 [0.005 to 0.84]
0.016
0.438
0.036
RichnessY Underweight
Low-normal weight
High-normal weight
Overweight
0.71 [0.50 to 1.01]
1.22 [0.93 to 1.60]
1 (reference)
0.71 [0.41 to 1.17]
0.055
0.150
0.179
*Odds ratio ((OR) = e(β) ) with 95% confidence intervals (95%CI) from multinomial logistic regression analysis. 
For independent variables measured on the continuous scale ORs should be interpreted as, per unit increase in the 
independent variable.
ϒAnalyzed in its standardised form by dividing “Total energy intake” for each child by the standard deviation of the 
variable.
YAnalysed in its standardised form by dividing “microbial richness” for each child by the standard deviation of the 
variable.
After performing univariate multinomial regression analysis to select bacterial groups 
(amongst 130) that were associated with the four trajectories, we obtained 17 bacterial 
groups for which the association was statistically significant. Upon controlling for 
multiple testing using FDR with a cut-off of less than 0.25 only 10 microbial groups 
(Burkholderia, Sutterella wadsworthia et rel., Eubacterium hallii et rel., Clostridium nexile 
et rel., Butyrivibrio crossotus et rel., Bacteroides vulgatus et rel., Bacteroides fragilis et rel., 
Lachnospira pectinoschiza et rel., Clostridium orbiscindens et rel., and Prevotella tannerae 
et rel., Table 3) out of the 17 remained statistically significant. The direction of the 
associations is illustrated in Supplementary Table 1.
Table 3. Bacterial groups that remained statistically significantly associated with BMI 
z-score trajectories after FDR correction*
Genus-like level bacterial group Raw p-value FDR adjusted P-value
Bacteroides fragilis et rel. 0.0070 0.1221
Bacteroides vulgatus et rel. 0.0069 0.1221
Burkholderia 0.0017 0.1056
Butyrivibrio crossotus et rel. 0.0055 0.1221
Clostridium nexile et rel. 0.0045 0.1221
Clostridium orbiscindens et rel. 0.0110 0.1613
Eubacterium hallii et rel. 0.0024 0.1056
Lachnospira pectinoschiza et rel. 0.0074 0.1221
Prevotella tannerae et rel. 0.0150 0.1980
Sutterella wadsworthia et rel. 0.0019 0.1056
*No point estimates available as this is just an overall association summed over the four trajectories. Hence only a p-value 
is obtained indicating the presence of an association with at least one of the trajectories.
In order to determine microbial taxa (potentially non-linear or combinatorial) that were 
associated with the four trajectories, we additionally applied the RF machine learning 
technique. The four latent trajectories were used as classes and the microbial taxa as 
features. Unfortunately, the average classification error (out of bag error over 100 separate 
RF analyses) for this dataset, even after feature elimination, was on average 59.2%. Due 
to this high percentage of error, we did not continue with RF analysis of this dataset. 
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Discussion 
The heterogeneity in weight development during childhood poses a challenge for 
researchers to identify and characterise regular or irregular patterns of BMI fluctuations 
in population-based studies and to relate these patterns to different risk factors in life. 
Using GBTM, we identified four (latent) subgroups of distinct developmental courses 
for BMI z-scores measured in children from 6-10 years of age within the KOALA Birth 
Cohort Study in the Netherlands. These BMI z-score trajectories were characterised 
as underweight, low-normal weight, high-normal weight, and overweight. Latent 
trajectories were also found to be associated with the established risk factors of childhood 
overweight including, physical activity and total energy intake.
The general patterns and number of trajectories identified in our study were consistent 
with results of several previous studies on populations with a similar age range.35,36 Likewise 
a recent review on BMI trajectories reported the existence of four latent subgroups 
characterised by high and low trajectories, both relatively stable over time, showing 
that the group of developmental patterns of BMI differed more in level (different onset 
between groups) than in shape37 Trajectories identified in a previous study using the 
same statistical methodology revealed that the changes in the developmental patterns 
only occurred between the ages of 1 and 4 years while no directional changes in patterns 
occurred between 4 to 10 years of age.10 All together the empirical evidence suggest 
that growth patterns (both in intercept and slope) are more heterogeneous in studies 
performed before six years of age as compared to studies performed in children above 
the age of 6 years. Therefore, early infancy (from birth to 1-5 years) could be considered 
as the most critical period to monitor childhood weight development.
We found that children with high microbial diversity at baseline had a substantially lower 
likelihood of belonging to the underweight as well as the overweight trajectories, whereas 
a borderline significantly lower microbial richness was observed for the underweight 
children. A healthy gut microbial ecosystem is generally thought to be characterised by 
high microbial richness and diversity, presumed to indicate a more stable and resilient 
state of this ecosystem.38 A lower richness/diversity of the gut bacterial communities 
has been reported in malnourished children39, subjects with obesity, and overweight as 
compared to normal weight individuals.25,26 Our study is therefore in accordance with 
previous studies, implying that reported associations of microbial diversity and richness 
with weight status are also observed when growth trajectories in a population of healthy 
children are being used.
We are not aware of any previous human study that has attempted to investigate the 
association between the gut microbiota composition and BMI z-score trajectories in 
children. We used Random Forests, a supervised machine learning technique, which is 
a particularly powerful classifier that can exploit non-linear relationships and complex 
dependencies between bacterial groups.28,29 In addition, several studies have shown that 
RF is very efficient in handling multinomial dependent variables.40-42 However, RF failed 
to identify bacterial candidates of the gut microbiota that could differentiate the four 
different trajectories. The performance of RF was compared with another classification 
method known as univariate multinomial baseline-category logit model while controlling 
for multiple testing using a 25% FDR. Using this statistical method, we identified ten 
bacterial groups that were associated with the trajectory groups. Why RF was unable to 
identify bacterial groups that could differentiate between the trajectories might be due 
to the fact that our data was unbalanced. The majority of children were allocated to 
the low-normal and high-normal weight trajectories, whereas the overweight trajectory 
consisted of only a very small number of children. In such a case, RF tends to train 
the data in favour of the two normal weight trajectories that include the majority of 
subjects. Univariate analyses on the other hand consider each bacterial group separately, 
ignoring any correlations that may exist between bacterial groups, and making use of the 
entire dataset (i.e. data is not separated into a training and test set). In this explorative 
study, where we used a relatively lenient FDR cut-off of 0.25, univariate analysis gave us 
a list of ten potentially interesting bacterial groups, whereas RF did not. 
One of the strengths of the current study is that weight development of a population of 
healthy children was monitored over time. The availability of variables related to BMI 
such as physical activity, total energy intake, and BMI z-scores measured by trained 
nurses during home visit enabled us to evaluate the validity of the generated trajectories. 
Finally, the use of GBTM to generate different patterns of weight development in children 
provided a deeper insight into distinct patterns of childhood weight development over 
a defined period between 6-10 years of age. The identified latent trajectories convey the 
heterogeneous nature of BMI z-score over time, facilitating their clinical interpretation 
while relating them to the gut microbiota composition. These trajectories are not real, 
fixed entities, and should not be interpreted as such (fallacy of reification), but rather as 
longitudinal features of the data. 
Some of the limitations in our study include the relatively small sample size and number 
of repeated measures over time (only 4 time points) and the fact that the gut microbiota 
composition of children was only available at a single time-point (baseline). Moreover, 
for simplicity, we opted for the classify-analyse strategy when linking the identified latent 
trajectories to the microbiota: first children were classified into one of the extracted 
trajectories (based on the maximum posterior probability of assignment) and the classes 
were subsequently treated deterministic in further inferential analyses.  
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In conclusion, we identified a total of four BMI z-score trajectories across the ages of 6 to 
10 years using GBTM. With this study we illustrated how the identification of unique 
patterns of childhood growth development by means of GBTM might be used to study 
the role of the microbiome in weight development within the context of longitudinal 
studies. This may aid other researchers within this research field to implement such 
methods. 
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SUPPLEMENTARY MATERIAL
Supplementary Table 1. Associations of ten bacterial groups obtained from univariate 
multinomial logistic regression with BMI trajectories 
Bacterial group Underweight
Low-normal 
weight
High-normal 
weightx Overweight
Bacteroides fragilis et rel. 0,36 0,40 0,00 -2,57*
Bacteroides vulgatus et rel. -0,34 0,34 0,00 -1,64*
Burkhoderia 2,89* 0,42 0,00 -5,76*
Butyrivibrio crossotus et rel. -0,35 1,33* 0,00 -0,85
Clostridium nexile et rel. -1,91* 0,35 0,00 -0,02
Clostridium orbicindens et rel. -2,42* -0,45 0,00 -1,02
Eubacteriun hallii et rel -2,56* -0,35 0,00 1,09
Lachnospira pectinoschiza et rel. -0,85 1,13* 0,00 -0,22
Prevotella tannerae et rel -0,23 0,67 0,00 -2,05*
Sutterella wadsworthia et rel. 2,38* 0,95 0,00 -1,36
*Bacterial group significantly associated with each BMI z-score trajectory
xIndicates reference category (high-normal weight) with log-odds β estimates = 0
Red colour indicates negative associations
Green colour indicates positive associations
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 Supplementary Figure 1. Six BMI z-score trajectories
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a)
b)
c)
Supplementary Figure 2. Boxplots displaying the distribution of; a) BMI measured by 
trained research assistants b) total energy intake c) total physical activity across BMI z-score 
trajectory groups with means±SDs, and outlier points.
Supplementary Figure 2. Boxplots displaying the distribution of; a) BMI measured by 
trained research assistants b) total energy intake c) total physical activity across BMI 
z-score trajectory groups with means±SDs, and outlier points.
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The main aims of this thesis were to: 1) examine associations between the gut microbiota 
composition and childhood (over)weight development; 2) examine the impact of 
childhood exposure to oral antibiotics and (over)weight development; and 3) address 
the methodological challenge of reducing high dimensional data of the gut microbiota 
in relation to latent BMI z-scores trajectories. To address these aims, a combination 
of advanced molecular microbial methods, a well-designed prospective epidemiological 
study and state-of-the-art biostatistical methods were used. A schematic overview of the 
main findings in this thesis is presented in Figure 1.
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Summary
In Chapter 2, the association between the intestinal microbiota composition at 1 month 
of age and childhood weight development, measured repeatedly between the ages of 1 
and 10 years, was investigated using data from the KOALA Birth Cohort Study. This 
cohort consists of two recruitment groups, a group with a conventional lifestyle was 
recruited from an ongoing prospective cohort study on pregnancy-related pelvic girdle 
pain (conventional recruitment group) and a second group was recruited through 
alternative channels, organic food shops, Steiner schools, magazines and anthroposophic 
doctors and midwives (alternative recruitment group). We found that gut colonization 
with Bacteriodes fragilis group at one month postpartum in the conventional recruitment 
group was significantly associated with a higher BMI z-score, but only among infants 
with a low fibre intake. B. fragilis counts in children that were colonized were positively 
associated with BMI z-score in children from the conventional recruitment group with 
a high-fibre diet, but negatively among those with a low fibre intake and among children 
from the alternative recruitment group. 
The early infant gut microbiota is susceptible to changes by a number of environmental 
factors such as mode of delivery, type of infant feeding and antibiotic use.1-4 At 2–3 
years of age, an adult-like intestinal microbiota composition is established5-8, although 
maturation of the microbiota may still continue for several years. In Chapter 3, using 
the HITChip, we comprehensively characterised the gut microbiota composition of 
children at age 6-7 years, when its composition is assumed to be more resilient. We 
then investigated the association between the gut microbiota composition at this age in 
relation to the anthropometric outcomes BMI z-score weight z-score, and overweight. 
Using Redundancy Data Analysis (RDA), we found that part of the variation in the 
gut microbiota composition of these children was accounted for by the cumulative 
abundance of Prevotella melaninogenica et rel., Prevotella oralis et rel., Dialister, and 
Uncultured clostridiales II (UCII). The anthropometric outcomes and potential 
confounders explained very little of the variation in the overall microbiota composition. 
However, the abundances of several specific bacterial groups were associated with the 
anthropometric outcomes BMI, weight, and overweight. Akkermansia, and Bryantella 
formatexigens et rel. were found to be consistently associated with all three anthropometric 
outcomes while Sutterella wadsworthia et rel. was negatively associated with BMI and 
overweight. With regards to bacterial groups exhibiting a bimodal distribution, higher 
abundance of UCII was found to be inversely associated with all three outcomes under 
study while higher abundance of Prevotella (melaninogenica et rel. and oralis et rel.) was 
inversely associated with overweight.
Taken together, Chapter 2 and 3, demonstrate that specific bacterial groups of the gut 
microbiota are associated with childhood overweight. In chapter 2 only a total of 5 
bacterial genera and species were considered whereas in chapter 3 we used the HITChip 
to carry out an in-depth characterisation of the gut microbiota composition identifying 
130 genus-like bacterial groups. Even though both studies considered B. fragilis (at 
the genus level) in association to childhood over(weight) development, we only found 
associations for B. fragilis group in faecal samples collected at 1 month of age, and 
these associations were dependent on the level of fibre intake. Due to differences in age 
at faecal sampling, study design (longitudinal versus cross-sectional), and method of 
microbial identification, results are not directly comparable. Moreover, Bervoets et al.9 
suggested that different species within the B. fragilis group might be responsible for the 
seemingly contradictory associations with weight development by showing that more B. 
fragilis was present in individuals suffering from obesity and more B. vulgatus in control 
subjects. Differences in the species composition of the B. fragilis group could explain 
both the opposite findings for the two recruitment groups at the age of 1 month, as well 
as the absence of an association at school-age. 
Considering the fact that, next to bacteria, other microbial groups within the intestinal 
tract might influence host metabolism and energy balance, in Chapter 4 we examined 
the presence of archaea (M. smithii and M. stadtmanae) in the faecal samples of 472 
children at age 6-7 years in association with childhood weight development. M. smithii, 
the dominant archaeal species in the human gut, was associated with higher weight 
z-scores and an increased likelihood of being overweight, with children harbouring 
the highest levels of this archaeon being at the highest risk. The biological interaction 
between archaea and bacteria was not investigated. A study by Samuel and Gordon, 
2006,10 actually showed that M. smithii played a critical role in facilitating an increased 
capacity of B. thetaiotaomicron to digest polyfructose-containing glycans leading to 
increased production of short-chain fatty acids (SCFAs) and total liver triglycerides in 
mice. Mice colonized with B. thetaiotaomicron and Desulfovibrio piger instead of M. 
smithii did not show such an effect. These biological interactions have not yet been 
investigated in humans and therefore should be considered for future studies. 
Antibiotics have been reported as one of the factors affecting the composition of 
the gut microbiota11-13 and have also been reported to be associated with childhood 
overweight14-17. In Chapter 5, we investigated the timing, frequency and type of 
antibiotic exposure during the first 10 years of life in association with (over)weight 
across this period in 979 children participating in the KOALA Birth Cohort Study. 
We found that exposure to a single course of antibiotics in the first 6 months of life, 
as well as ≥2 courses during the first two years of life were associated with increased 
weight and height z-scores. These associations were stronger for exposure to β-lactam 
antibiotics. We found no associations between antibiotic exposure beyond the second 
year of life and childhood weight development. This indicates that early childhood is 
a critical period where exposure to antibiotics may have most pronounced effects on 
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childhood overweight, possibly mediated by microbial perturbations. Our findings 
support existing evidence from previous studies14-17 that early exposure to antibiotics is 
associated with childhood (over)weight development. Our study is one of the first large-
scale prospective studies that included information on the timing, frequency and type of 
antibiotic used during the first 10 years of life, in relation to anthropometric outcomes 
measured repeatedly over this entire follow-up period. 
In the above-mentioned longitudinal studies, we investigated associations of microbial 
or antibiotic exposures with BMI over time while ignoring the fact that there may be 
distinct developmental patterns of growth between children. In Chapter 6, we aimed 
to identify such developmental patterns. Using Group-based trajectory modelling 
(GBTM), we identified 4 distinct latent BMI z-score trajectories in our study population. 
Latent trajectories were found to be associated with established risk factors of childhood 
overweight, including physical activity and total energy intake. Using statistical methods 
to reduce the high dimensional data of the gut microbiota in relation to these latent 
trajectories, we identified ten bacterial groups that were associated with the trajectories. 
This shows that GBTM can be used to summarize complex developmental patterns of 
children into a single multi-category variable, which facilitates the reduction of high 
dimensional data in relation to this.
Methodological considerations
Reliability of  faecal samples
Due to the relative ease and non-invasiveness of stool collection, most of the studies on 
the intestinal microbiota, including ours, have been performed using this sample type. 
It can be debated whether stool samples are the best sample type to gain insight into the 
intestinal microbiota since the microbial profile of faeces is substantially different from 
that of the mucosa, which itself can vary along the length of the gastrointestinal tract.18 
However, colonic biopsies are more difficult to obtain, which makes collection of biopsies 
not feasible within the context of large-scale epidemiological studies, especially when 
involving children. Moreover, patients are required to take laxatives before colonoscopy 
which may also significantly alter the gut microbiota composition.19 It can be assumed 
that despite all activities that go on along the passage of the intestinal tract, most viable 
as well as nonviable commensal intestinal bacteria will still be detectable in faeces with 
molecular methods. However, it is unlikely that analysing microbiota composition in 
faeces is representative of all important intestinal micro-organisms. Hence, using faeces 
represents a limitation of most studies on the gut microbiota even though at this point 
faeces remain the only reliable sample in large non-invasive studies.20
Collection and processing of  faecal samples
In order to minimise bias and transport time of faecal samples, detailed instructions were 
sent to parents directing them on how to collect their child’s faeces. Upon collection, faecal 
samples were sent to the laboratory by mail. Issues arise because anaerobic conditions are 
not maintained during faecal sample collection, transportation and laboratory analysis. 
This may have led to increased proliferation of certain types of microbes whereas others, 
especially strictly anaerobes, might die during the course of sample transportation and 
handling.21 However, it is likely that the impact of sample handling and transport on the 
composition of the samples is less pronounced when molecular methods are used instead 
of traditional culture techniques, as the non-viable bacteria will still be detected.22 It can 
however not be ruled out that the potential overgrowth of some bacterial species and 
suppression of others, as well as degradation of bacterial DNA due to transportation 
could have influenced our results.23 In our study the transport time for faecal samples 
ranged from 1 to 3 days at ambient to room temperature. Several previous studies have 
shown that the microbial diversity and composition of faecal samples is much more 
affected by inter-individual differences and biases in molecular techniques rather than 
differences in short-term storage conditions, including storage for up to 2 weeks at 
room temperature.24,25 The method used for DNA extraction can also introduce bias 
as samples may contain both organisms that are more easily disrupted, such as gram-
negative species, and those that are more difficult to lyse, such as gram-positive species, 
mycobacteria, and spores.26 We have minimised the potential effect of this bias by using 
a widely used and validated protocol that combines both mechanical and enzymatic 
disruption.27
Temporal variations in microbiota composition
The studies presented in this thesis were based upon characterization of the faecal 
microbiota at the ages of respectively 1 month and 6-7 years of age. It is well-known 
that the microbiota in neonates is highly dynamic. By only examining the microbiota 
at a single time-point during infancy, some potential associations between the gut 
microbiota and weight development might have gone undetected. By the age of 2-3 
years an adult-like microbiota has established.5-8 Hence, at age 6-7 years the microbiome 
becomes more adult-like with a more stable composition, although the composition 
might still be affected by bacterial infections, antibiotic treatment, as well as changes in 
lifestyle and dietary patterns4 over time.
Validity of  outcome measures
We used sex- and age-standardised BMI as a measure of adiposity classification. BMI 
is not only determined by body fat mass but also by lean mass, and therefore may 
misclassify children into the overweight category when actually they are not overly fat. 
However, several studies have indicated a positive correlation between BMI and body 
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fatness. The World Health Organisation (WHO) also recommends BMI as the most 
useful population level measure of overweight and obesity.28 Together this justifies the 
use of BMI in our study as a measure to track childhood (over)weight development. 
The repeated weight and height measurements used in our longitudinal analysis were 
parent-reported. A validation study using data from the KOALA Birth Cohort Study, 
found an underestimation of overweight with parent-reported data compared to data 
collected during home visits.37 This so-called differential misclassification, where the 
rate of misclassification depends on BMI, with more misclassification for overweight 
and obese individuals, may have led to both and under- or overestimation of the true 
associations in our studies. However, the fact that we had repeated measurements might 
have partially off-sets this drawback. 
Study design 
The current thesis contains both cross-sectional and longitudinal analyses. Longitudinal 
studies take into account associations between gut microbiota and weight development 
over a defined period of follow-up and have been considered to provide better evidence 
of causality than cross-sectional studies.29 The majority of previous studies on the role 
of the gut microbiota on (over)weight were of cross-sectional design or, if longitudinal, 
did not address the transitional evolution of childhood (over)weight over an extended 
period of time. The longitudinal study design therefore is one of the major strength 
of our studies. In addition, this thesis contains the first study that has used GBTM 
to generate longitudinal childhood growth patterns (BMI z-score trajectories) while 
associating them to gut microbiota composition. However, longitudinal studies have 
their own limitations, such as loss-to-follow up that leads to a reduction in sample size 
and hence decreases the statistical power to detect associations. In our study, loss-to-
follow up rates was lowest among children from parents with a higher economic status 
and with a healthier lifestyle, implying that most of the drop-outs were the unhealthier 
children, which might have resulted in a smaller chance of finding associations. 
Observational studies usually generate information on associations and not on causal 
relations. We therefore cannot rule out the fact that reverse causation might have 
occurred, particularly in the cross-sectional analyses on the gut microbiota and childhood 
body weight at the age of 6-7 years. Evidence for a causal role of the gut microbiota 
in overweight development comes mostly from animal studies, while a few human 
studies provide some evidence of causality by means of the effects of gut microbiota 
transplantation.30,31 With this in mind, evidence from previous studies and findings 
from this thesis further strengthens the hypothesis that the gut microbiota influences 
childhood over (weight) development.
Generalizability
Our study population consisted entirely of Dutch Caucasian children hence results 
might not be generalizable to children with another ethnic or racial background. Indeed, 
the gut microbiota composition has been shown to vary between populations from 
different geographic regions and racial backgrounds.5,32 It is however, unclear whether 
ethnicity or racial background has a direct impact on the gut microbiome since most of 
these variations between populations seem to be caused by differences in dietary habits. 
Nevertheless, there is a great need for similar studies in other regions of the world.
Future perspectives/recommendations
Several studies have reported associations between the gut microbiota and childhood 
overweight but till date, there is a lack of consensus in the findings between these studies. 
These inconsistent findings might, at least to some extent, be explained by differences 
in experimental techniques (DNA isolation, microbial identification) that affect the 
observed composition of the human microbiome. When multiple studies across the 
world are being carried out on large-scale cohorts while utilizing the same methods of 
DNA isolation and comprehensive microbial identification, this may likely clarify some 
of the present uncertainties. 
In addition, most of the studies performed so far have been case-control studies. Such 
studies are important in actually providing the initial step in investigating if there is an 
association between the gut microbiota and overweight. However, causality cannot be 
established with such studies. Prospective studies or birth cohorts with multiple follow-
up time-points from birth throughout infancy and childhood, and with faecal samples 
obtained at the same time of anthropometric outcomes will enable us to monitor the 
composition of the microbiome and its association to weight development. Some human 
intervention studies involving the transplantation of gut microbiota obtained from 
healthy donors to diseased recipients have already been carried out.30,31 Such studies 
could be used to investigate if effects of the microbiota are causal. However, such studies 
also have their drawbacks in that it carries the risk of transferring either unknown or 
undetectable pathogens. A recently reported type of faecal transplantation known as 
synthetic faecal transplantation seems to overcome the limitations of the direct or native 
faecal transplantation. Synthetic faecal transplantation utilises microbial strains from 
the faeces of a healthy donor that has been cultured and transplants these strains into an 
unhealthy recipient.33,34 Future studies, could therefore implement this method of faecal 
transplantation in place of the native faecal transplantation to investigate the causal 
effect of the gut microbiota on childhood over (weight) development. 
Such studies should be extended to the different continents of the world to enable us to 
have a deeper insight into whether effects are similar in different geographic and ethnic 
populations. In addition, the studies should be able to carry out a high interrogation of 
the gut microbiota composition up to the species level and hence advanced statistical 
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methodology for high dimensional data reduction and longitudinal data analysis are 
needed. The investigation of biological interactions between different microbial groups 
and the joint effect of these interactions on childhood weight development may further 
add meaning to the existing evidence. 
Above all, it is important to mention that this is still a very new area of research which 
so far has revealed new leads as to how the gut microbial composition relates to different 
aspects of human health especially childhood obesity. Akkermansia has consistently 
been reported by previous studies and our study as being inversely associated with body 
weight in both mice35 and humans.36,37 Methanogenic archaea (specifically M. smithii) 
are also a group of gastrointestinal microorganisms that have been found to be positively 
associated with body weight. Further studies (e.g. trials) in which Akkermansia are being 
used as probiotics and animal studies which involve the administration of only archaea 
or archaea in combination with other microbes that compete with archaea for hydrogen 
are warranted. This will enable us to further confirm if the associations between 
Akkermansia, methanogenic archaea and weight development are causal. We also 
identified bacterial groups that have not been previously reported to be associated with 
childhood overweight such as Sutterella wadsworthia et rel. and Bryantella formatexigens. 
This will require the performance of mechanistic studies for such bacterial group to 
actually investigate their mechanisms involved in weight development. Future studies 
should aim at identifying what are beneficial (“good”) and non-beneficial (“bad”) 
microbes for an ideal gut microbial ecosystem for the human health. 
As research in this field is ongoing, we hope that our findings and those of others will 
help in providing unique solutions to the growing epidemic of childhood obesity. To 
achieve this aim, the gut microbiota should be studied together and in interaction with 
established risk factors of overweight such as diet and physical activity.
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The purpose of research is obtaining results that can be put into use to help the society. 
This implies that the results of studies should have implications for policy and project 
implementation. In other words, this is known as valorisation, which can be fully 
defined as: “The process of value-creation out of knowledge, by making this knowledge 
suitable and available for economic or societal utilisation”.1 The commercialisation 
of knowledge by generating patents and license contracts is an example of economic 
utilisation while societal utilisation involves making knowledge generated from research 
findings available to the population, policy makers and public organisations.
The studies presented in this thesis were aimed at: 1) examining associations between 
the gut microbiota composition and childhood (over)weight development; 2) examining 
the impact of childhood exposure to oral antibiotics on (over)weight development; and 
3) addressing the methodological challenge of reducing high dimensional data of the gut 
microbiota in relation to latent BMI z-score trajectories. We showed that both the gut 
microbiota composition and early exposure to antibiotics were associated with childhood 
(over)weight development. However, due to their observational nature, studies in this 
thesis only yield associations and not causal relationships. Therefore, in this chapter, I 
will present some recommendations with regards to the findings obtained during my 
PhD project and how these findings can be applied to overcome this problem. This 
may aid in the prevention of overweight/obesity in children who are in the process of 
developing this and in the treatment of children already suffering from overweight/
obesity.
A large percentage of the population is already aware of some of the factors that are 
known to be associated with obesity, but few individuals are aware of the millions of 
micro-organisms present in our gastrointestinal tract and their relation with health. 
Moreover, most results obtained from research are not accessible to the public but 
mostly found in databases that can only be obtained through subscription. In our study, 
the population of interest were children hence our targeted audience are parents, general 
practitioners, and especially paediatricians. In my opinion the first move will be to 
inform parents on the importance of the gut microbiota on childhood health, including 
its potential association with childhood obesity. Creating awareness of the importance 
of the gut microbiota in health will go a long way to help parents improve the lifestyle 
of their children. 
We showed that early exposure to antibiotics was associated with childhood weight 
development. In addition, antibiotics have been reported to have a perturbative effect 
on the composition of the gut microbiota and lead to an increase of bacterial strains that 
are resistant to antibiotics. The major concern will be to minimise the prescription of 
antibiotics to children suffering from viral self-limiting respiratory tract infections. The 
Netherlands has been known internationally for its leading role in increasing awareness 
about antibiotic use, by implementing restrictive antibiotic prescription guidelines. 
Meanwhile a lot still has to be done in other countries to achieve this aim e.g. southern 
European, Asian, and developing countries, and the United States of America.2,3 
Therefore, strict guidelines for the prescription of antibiotics should be established and 
in countries with already established guidelines, adherence of GP’s to the guidelines 
should be monitored for adequate antibiotic prescription. However, these guidelines 
are mainly based on antimicrobial susceptibility and resistance. In addition to existing 
cartoons to create awareness for antibiotic resistance (e.g. the Luke and Lucey cartoon 
“Auntie biotica”), cartoons demonstrating the negative impact of antibiotics that have 
direct impact on the patients such as the perturbation of the microbiota and associated 
effects on weight could be produced to help deliver the message to parents or the society.
To help prevent the overuse of antibiotics and their potential detrimental health effects, 
medical doctors should restrict the prescription of antibiotics according to the national 
guidelines. They should be able to educate their patients (especially parents) on the 
disadvantages of antibiotics and with the help of the public health sector, produce 
cards/flyers containing this information and share them. In this regards, this will help 
create awareness of antibiotics usage especially in children and will prevent them from 
unnecessary antibiotic usage.
For the treatment of childhood overweight/obesity, this will require further research 
to critically investigate if the associations seen in our and other studies are actually 
causal as most of the previous studies have been cross-sectional and causality cannot be 
established by such studies. Prospective studies or birth cohorts with multiple follow-
up time-points from birth throughout infancy and childhood, and with faecal samples 
obtained at the same time of anthropometric outcomes will enable us to better monitor 
the composition of the microbiome and its association to weight development. This 
should also include an extensive documentation of lifestyle factors to better control for 
confounding factors. Some human intervention studies involving the transplantation 
of gut microbiota obtained from healthy donors to diseased recipients have already 
been carried out in adults.4,5 Such studies could be used to investigate if effects of the 
microbiota are causal in both adults and children. Future studies, could then implement 
the method of synthetic faecal transplantation 6,7 to investigate the causal effect of the gut 
microbiota on childhood over (weight) development. Such studies should be extended 
to the different continents of the world by carrying out a high interrogation of the gut 
microbiota composition up to the species level to enable us to have a deeper insight 
into whether effects are similar in different geographic and ethnic populations. Also 
advanced statistical methodology for high dimensional data reduction and longitudinal 
data analysis applied to data with larger sample sizes are needed. 
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Above all, it is important to mention that this is still a very new area of research which 
so far has revealed new leads as to how the gut microbial composition relates to different 
aspects of human health especially childhood obesity. Akkermansia has consistently 
been reported in previous studies, as well as in our study, to be inversely associated 
with body weight in both mice8 and humans.9,10 We therefore recommend further 
studies (e.g. trials) to investigate the potential use of Akkermansia as a probiotic with a 
positive effect on weight management. Methanogenic archaea (specifically M. smithii) 
on the other hand have been found to be positively associated with body weight. It is 
thought that to achieve a reduction or elimination of M. smithii from the colon, bacteria 
such as sulphate reducing bacteria (SRB) could be incorporated into the colon to 
outcompete the methanogens for H
2
. However, this should be preceded by experiments 
aiming at determining the conditions that would effectively reduce the methanogenic 
population.11 Future animal studies, which involve the administration of only archaea 
or in combination with other microbes that compete with archaea for hydrogen are 
warranted. 
Such studies might enable us to confirm causal relationships between Akkermansia, 
methanogenic archaea and weight development and provide new leads for intervention 
strategies such as the production of probiotics. Current evidence for probiotics in the 
prevention and treatment of most diseases is very limited. However, most probiotic 
strains and products were initially not specifically selected to treat or prevent a single 
disease. Therefore, if causality is finally established, these new candidates that appear to 
be specifically involved in weight development might appear to be more promising by 
administering the bacteria to overweight subjects through probiotics. From all previous 
studies conducted in this area of research including ours, there are strong indications 
that the gut microbiota remains a promising target in the fight for childhood (over)
weight development. However, only when causality is established can we be very sure to 
start applying the findings obtained for treatment purposes.
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